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ABSTRACT
Action potentials initiate via the voltage-dependent opening of plasma 
membrane-associated sodium channels. The number and type of sodium channels in a 
neuronal membrane determine the quantity of sodium current that results from a given 
stimulus. The expression of sodium channels in neurons is plastic, and is not only 
altered by injury and disease, but also by subtle changes in physiologic environment. In 
this dissertation, the effect of neuronal activity level on the expression and function of 
sodium channels is explored within several neuronal populations. First I examine the 
response of vasopressin-producing magnoceliuiar neurosecretory cells of the supraoptic 
nucleus to the hyperosmotic setting of chronic diabetes mellitus. Evidence for up-
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regulation of sodium channels, and metabolic overactivation leading to apoptosis, in 
these neurons is presented. Second, ! test the effect of electrical stimulation on 
expression of sodium channels in cultured sensory neurons. And lastly, I demonstrate 
that there is dysregulated sodium channel expression within cortical neurons in a 
specific region of the brain in a model of absence epilepsy.
Together, the results of these experiments support the hypothesis that the 
activity level of a neuron influences its rate of production and expression of sodium 
channels. Identification of this phenomenon could lead to new therapeutic strategies for 
1) limiting end-organ pathogenesis in diabetes (by reducing magnoceliuiar 
neurosecretory cell sodium channel activity, thereby preventing chronically up-regulated 
vasopressin secretion), 2) treating pain (by using stimulation to normalize post-injury 
sodium channel expression and reduce neuronal hyperexcitability), and 3) treating 
epilepsy (by targeted modulation or block of seizure-initiating sodium channel activity). 
Development of novel therapeutic approaches will depend on further characterization of 
the regulatory feedback mechanism that links changes in neuronal activity level with 
modulation of sodium channel expression.
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CHAPTER 1
INTRODUCTION AND BACKGROUND
1.1 VOLTAGE-GATED SODIUM CHANNELS
Neuronal Information transmission occurs by voltage-gated sodium channel 
(VGSC)-dependent action potential firing. There are at least eight VGSC genes 
expressed throughout the nervous system, each with different tissue specificities and 
functional characteristics (Akopian et al., 1996; Black et al., 1996; Catterall, 2000; Dlb- 
Hajj et al., 1998a; Goldin et al., 2000; Kayano et al., 1986; Noda et al., 1986b; 
Sangameswaran et al., 1996; Schaller et al., 1995; Toledo-Aral et al., 1997) (Table 1.1). 
The distinct combination of VGSCs present in a neuronal membrane determines Its firing 
pattern and electrical conduction properties. VGSC expression Is a dynamic process, 
and alterations In physiological state as well as Injury and disease Induce changes In 
sodium channel expression, which lead to changes In neuronal behavior.
The VGSC Itself Is a polypeptide whose primary structure consists of a 260 kD a- 
subunlt associated with two p subunits (Isom et al., 1994), p i (36 kD) (Isom et al., 1992) 
and p2 (33 kD) (Isom et al., 1995). While sodium currents can be elicited by functional 
expression of the a-subunit alone (Goldin et al., 1986; Noda et al., 1986a), the 
P subunits are required for normal physiologic voltage-dependent kinetics (Isom et al., 
1992; Isom et al., 1995). The a-subunIt Is comprised of four Internally homologous 
domains (l-IV), each of which contains six transmembrane segments (S1-S6). The pore.
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through which sodium ions flow upon channel opening, is formed by close association of 
hydrophilic residues within S5 and S6 of each domain. Positively-charged residues on 
S4 endow the channel with voltage sensitivity.
Table 1.1. Voltage-gated sodium channel (VGSC) a-subunits (Goldin et al., 2000).
Channel Former name Expression
Navl.1 rat 1, SCN1A CNS/PNS
Navi .2 rat II, SCN2A CNS/PNS
N avi.3 rat III CNS/PNS
Navi .4 SkMI, p1 skeletal muscle
N avi.5 SkM2, HI heart muscle
N avi.6 NaCh6, PN4, Scn8a, Cer III CNS/PNS
N avi.7 hNE, PN1 PNS/Schwann cells
N avi.8 SNS, PN3 PNS
N avi.9 NaN, SNS2, PN5, Sen 12a PNS
1.2 PLASTICITY OF VGSC EXPRESSION IN INJURY AND DISEASE
Neuronal firing is critically dependent on the repertoire of sodium channels within 
the plasma membrane. Injury-induced changes in expression of multiple sodium channel 
subtypes can lead to altered firing properties including spontaneous ectopic activity and 
hyperexcitability (Rizzo et al., 1996). This effect has been studied in dorsal root ganglia 
(DRG) sensory neurons after a variety of injuries. Molecular analysis has revealed that 
different sodium channel genes underlie different currents recorded in DRG neurons: 
Aa/p neurons express tetrodotoxin-sensitive (TTX-S) currents which are generated by 
Navl.1, N avi.6 and N avi.7, while C-type neurons preferentially express tetrodotoxin- 
resistant (TTX-R) currents, generated by Navi .8 and Navi .9 (Akopian et al., 1996; 
Cummins et al., 1999).
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Following sciatic nerve axotomy, a down-regu!ation of TTX-R current 
corresponding to sodium channel genes Nav1.8 and Nav1.9 has been demonstrated in 
C-type DRG neurons (Cummins and Waxman, 1997; Dib-Hajj et al., 1996; Dib-Hajj et 
a!., 1998a; Sleeper et al., 2000). In addition, a previously silent rapidly-repriming TTX-S 
current, corresponding to the sodium channel Navi.3, is expressed in the axotomized 
neurons. Up-regulation of Navi .3 has also been demonstrated in dorsal horn neurons 
following contusion spinal cord injury (Hains et a!., 2003). These changes are thought to 
occur, at least in part, as a result of decreased neurotrophic factor availability in the 
transected axons. NGF deprivation is known to decrease Navi .8 expression and its 
TTX-R current in cultured DRG neurons (Fjell et al., 1999b). These changes in sodium 
channel expression contribute to the increased firing frequency observed following 
axotomy. Hyperexcitability leading to ectopic and spontaneous firing may underlie 
initiation and maintenance of neuropathic pain.
In addition to direct nerve injury, application of inflammatory mediators also alters 
sodium channel expression in DRG neurons. Carrageenan, which causes localized 
erythema, edema, and hyperalgesia when injected subcutaneously, induced an up- 
regulation of Navi .8 mRNA and TTX-R current in C-type DRG neurons (Tanaka et al., 
1998). It is thought that increased peripheral levels of NGF (produced normally by 
fibroblasts, Schwann cells, and keratinocytes, and by immune cells during inflammation) 
may cause the up-regulation of Navi .8 in this model.
Sodium channel plasticity has also been demonstrated in several diseases. In 
streptozotocin (STZ)-induced diabetes, DRG neurons up-regulate mRNA and protein 
expression of NavI.S, N av i.6, and N avi.9, and down-regulate expression of N avi.8, 
after the onset of allodynia (Craner et al., 2002a). This effect is associated with a 
significant down-regulation of IGF and its receptor in diabetic DRG neurons (Craner et 
al., 2002b). There is also evidence for up-regulated VGSC expression within cortical
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
neurons in experimentai epilepsy (Aronica et al., 2001; Bartolomei et a!., 1997; Gastaldi 
et a!., 1998; Vreugdenhil et a!., 1998). Increases in expression of VGSCs producing 
persistent currents, in particular, may contribute to the sustained depolarizations 
characteristic of seizure activity (Segal and Douglas, 1997; Segal, 2002).
In all of these examples, neuronal activity is altered based on changes in 
transcription of normal sodium channel genes. These so-called “transcriptional 
channelopathies” are distinct from other channelopathies characterized by either 1) 
mutations causing abnormal or absent channel protein, or 2) autoimmune and toxic 
effects causing altered channel function (Waxman, 2001). The ability of a neuron to 
remodel its electrogenic apparatus by altering the number and ratio of various sodium 
channels in its membrane is a focus of this dissertation.
1.3 ACTIVITY-DEPENDENT MODULATION OF EXPRESSION
Do changes in neuronal activity induce plasticity of VGSC expression? At the 
transcriptional level, VGSC gene expression is known to be growth factor dependent 
(Fjell et al., 1999a), but the effect of afferent stimulation and neuronal firing on VGSC 
gene expression remains unclear. It has been suggested that neurons adjust their gain 
and excitability by altering VGSC expression to adapt to, or react to, new input 
environments (Desai et a!., 1999; Spitzer, 1999; Stemmier and Koch, 1999; Waxman, 
1999a; Woolf and Salter, 2000). The underlying activity-dependent transcriptional 
signals for these modifications are only partially understood. There is some evidence 
that activity-dependent changes in sodium channel expression are mediated through 
changes in intracellular calcium levels, but much of this data, as will be discussed, is 
derived from experiments on non-neuronal sodium channels, for example. Navi .4 in 
skeletal myotubes (Brodie et al., 1989; Monjaraz et al., 2000; Offord and Catterall, 1989; 
Sherman and Catterall, 1984; Shiraishi et al., 2001).
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Since alterations in physiologic environment influence the functional output of a 
neuron, a link between neuronal activity level and VGSC gene expression is anticipated 
(Fig. 1.1). If properly characterized, this link might provide a new paradigm for 
therapeutic control of neuronal transcriptional sodium channelopathies by activity 
modulation.
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growth factors
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Fig. 1.1. The effect of neuronal activity on voltage-gated sodium channel expression is 
unknown, but likely involves regulatory feedback (question mark) that either directly or 
indirectly influences the activity of transcription factors.
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1.4 SPECIFIC AIMS
The objective of this dissertation is to identify whether changes in VGSC 
expression occur in experimental models where neuronal activity levels are altered. In 
Chapter 2, vasopressin producing neurons of the hypothalamic supraoptic nucleus are 
studied in the hyperosmotic setting of streptozotocin (STZ)-induced diabetes. In 
response to elevated serum osmolality, these neurons increase their synthesis of 
vasopressin. I demonstrate that the increased biosynthetic activity of these neurons is 
accompanied by up-regulated expression of two sodium channels, Navi ,2 and Nav1.6, 
and their currents. This molecular reorganization of the electrogenic apparatus enables 
these neurons to increase their firing, and this increases the depolarization-dependent 
calcium-mediated release of vasopressin. The long-term effects of this increased 
demand for vasopressin and up-regulated sodium channel expression are explored in 
Chapter 3, using 6 month STZ-induced diabetic animals. In these animals, apoptosis 
was detected in a sub-population of neurons within the supraoptic nucleus, indicating 
that chronic diabetes induces neuronal loss, possibly as a result of activity-dependent 
overactivation.
The effect of electrical activity on neuronal VGSC expression is examined in 
Chapter 4. Cultured embryonic mouse DRG neurons, which normally express high levels 
of N avis  and N av l9 , are known to down-regulate expression of these channels after 
NGF withdrawal. In these experiments I show that, using non-limiting concentrations of 
NGF, expression of N av lB  and N av l9  mRNA and protein are down-regulated following 
electrical stimulation. This finding provides direct evidence that sodium channel 
expression can be regulated and altered by changes in neuronal activity.
Epilepsy is a condition characterized by abnormally elevated neuronal activity, 
and therefore provides a useful model for studying activity-dependent changes in VGSC 
expression. I demonstrate that in a rodent model of absence epilepsy, mRNA and
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protein expression of Nav1.1 and Nav1.6 are up-regulated in layer ll-IV neurons 
specifically within the facial somatosensory region of the cortex, compared to controls 
(Chapter 5). This region of cortex approximately corresponds to the 
electrophysiologically-determined region of seizure onset in this model. The 
dysregulated sodium channel expression parallels the increase in seizure frequency and 
duration observed in these animals.
Activity-dependent modulation of VGSC expression is therefore explored within 
several neuronal populations, and the functional significance and implications of the 
observed changes are discussed within each chapter.
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CHAPTER 2
SODIUM CHANNEL EXPRESSION IN HYPOTHALAMIC 
OSMOSENSITIVE NEURONS IN EXPERIMENTAL DIABETES
2.1 SUMMARY
Vasopressin is synthesized by neurons in the supraoptic nucleus of the 
hypothalamus and its release is controlled by action potentials produced by specific 
subtypes of voltage-gated sodium channels expressed in these neurons. The 
hyperosmotic state associated with uncontrolled diabetes mellitus causes elevated 
levels of plasma vasopressin, which are thought to contribute to the pathologic changes 
of diabetic nephropathy. We demonstrate here that in the rodent streptozotocin model of 
diabetes there are increases in expression of mRNA and protein for two sodium channel 
a-subunits and two (3-subunits in the neurons of the supraoptic nucleus. Transient and 
persistent sodium currents show parallel increases in these diabetic neurons. In the 
setting of chronic uncontrolled diabetes, these changes in sodium channel expression in 
the supraoptic nucleus may be maladaptive, contributing to the development of 
secondary renal complications.
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2.2 INTRODUCTION
The role of the centra! nervous system in the pathophysiology of diabetes 
mellitus is incompletely understood. Vasopressin is synthesized in magnoceliuiar 
' neurosecretory cells (MNCs) of the supraoptic nucleus (SON) of the hypothalamus and 
released from the posterior pituitary in response to elevated plasma osmotic pressure. 
There is now evidence that prolonged elevated levels of vasopressin are a risk factor for 
the development of diabetic nephropathy, which can lead to end stage renal disease 
(Ahloulay et al., 1999; Bardoux et al., 1999). The amount of vasopressin released is a 
function of action potential firing in the MNCs. This firing, which occurs in a characteristic 
bursting pattern (Andrew and Dudek, 1983) is dependent on the opening of voltage- 
gated Na"' channels in the MNCs, and in fact, application of tetrodotoxin (TTX) to 
dissociated MNCs strongly reduces vasopressin secretion (Sperlagh et al., 1999).
At least eight types of voltage-gated sodium channels are expressed in neurons 
(Catterall, 2000; Goldin et al., 2000), each with different tissue specificities. These 
channels consist of an a-subunit which comprises the channel pore and voltage-sensor, 
and accessory p-subunits (Isom et al., 1994). Supraoptic MNCs express the Navi .2 and 
Navi .6 a-subunits, and p i and p2 subunits, under physiological conditions (Tanaka et 
al., 1999). Transcription of these channel subunits is up-regulated and increased 
numbers of functional subunits are inserted in the membranes of MNCs with chronic 
salt-loading, a maneuver that results in increased plasma osmolality; the increase in 
sodium channel expression can result in a lowered threshold for firing in the MNCs 
(Tanaka et al., 1999).
In this study we asked whether the hyperosmolality associated with diabetes 
could trigger a change in sodium channel expression in hypothalamic MNCs. After 
confirming in initial studies that sodium channels Navi .2 and Navi .6, but not N av i. 1 and
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Nav1.3, are present at significant levels in normal and diabetic SON, we focused on 
Nav1.2 and Nav1.6 and (31 and [32. We report here that in experimentally-induced 
diabetes, there is a previously undescribed change in the hypothalamus: molecular and 
functional alteration of MNCs by up-regulation of expression of specific a- and p-subunit 
sodium channel genes and insertion of additional functional channels into the 
membranes of these neurosecretory neurons.
2.3 MATERIALS AND METHODS
Induction of Diabetes. Adult male Sprague-Dawley rats (225-250 g) were injected with 
streptozotocin (STZ, 60mg/kg i.p., Sigma, St. Louis, Missouri). Plasma glucose (Encore 
Glucometer, Miles Inc., Elkhart, Indiana) and plasma osmotic pressure (Wescor model 
5500, Logan, Utah) were measured at intervals 2-6 weeks post-injection. Ten animals (5 
control, 5 diabetic) were studied 2-6 weeks after STZ injection using in situ hybridization, 
8 animals (4 control, 4 diabetic) using immunocytochemistry, and 10 animals (5 control, 
5 diabetic) using patch-damp electrophysiology.
In situ Hybridization. Rats were anesthetized with ketamine/xylazine (80/5 mg/kg, i.p.) 
and perfused with 4% paraformaldehyde in 0.14 M phosphate buffer. Brains were 
postfixed, cryoprotected and serial coronal sections (20 pm) including the supraoptic 
nucleus were cut. Control and diabetic sections were hybridized with isoform-specific 
riboprobes (Black et al., 1996) in parallel as described previously (Tanaka et al., 1999). 
Sense riboprobes yielded no signals on in situ hybridization (not shown).
Immunocytochemistry. Brains were postfixed, cryoprotected in PBS, and sections of 
SON (20 fim) were processed for immunocytochemistry as previously described
10
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(Tanaka et al., 1999) using antibodies to vasopressin (1:1000, Oncogene Research 
Products, San Diego, CA), or sodium channel subunits Navi .2 (1:100, Sigma), Navi .6 
(1:100, Alomone, Jerusalem, Israel), and the p2-subunit (1:100, Alomone). Control 
experiments without primary or secondary antibody incubations showed no staining.
Data Analysis. Quantitative microdensitometry of hybridization and immunostaining 
signals were performed using a Nikon Eclipse E80G light microscope (20X objective) and 
IPLab Image Processing software (Scanalytics Inc., Fairfax, Virginia). Signal intensities 
were obtained by manually outlining the SON and using IPLab integrated densitometry 
functions to calculate mean signal intensities for the selected areas. Background optical 
intensity measured adjacent to the SON in each section was subtracted from all signals; 
the results are expressed as means ± SEM. Diabetic tissue was compared to controls 
processed in parallel. Control and diabetic groups were compared using non-paired t- 
tests.
Patch clamp electrophysiology. MNCs in the SON were acutely dissociated from 
control and diabetic animals as previously described (Tanaka et al., 1999; Widmer et al., 
1997). MNCs were recorded in the whole-cell patch-clamp configuration as described 
previously (Tanaka et al., 1999) within two hours with an EPC-9 amplifier (HEKA 
electronics, Lambrecht/Pfaiz, Germany) using 1-2 MQ electrodes (85% series resistance 
compensation). The pipette solution contained (in mM): 140 CsF, 2 MgCIa, 1 EGTA, and 
10 Na-HEPES (pH 7.3) and the saline solution (above) was used as extracellular bath. 
All recordings were conducted at room temperature (-21 °C).
11
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2.4 RESULTS
Induction o f diabetes. All animals injected with STZ developed hyperglycemia (>250
pg/dl) and elevated plasma osmotic pressure compared with control animals injected 
with vehicle (control 294.3±6.5 mOsm; diabetic 314.4±7.6 mOsm; p<0.01). Animals were 
studied 2-6 weeks after injection with STZ. Vasopressin expression was up-regulated in 
the diabetic SON (Fig. 2.1).
Up-regulation o f sodium channel mRNA and protein In the diabetic SON. Because 
our earlier studies (Widmer et al., 1997) demonstrated that N av i.2, NavI.S, p i and p2 
(but not Navl.1 or NavI.S) are present in MNCs and are up-regulated by salt-loading, 
we focused on these channel subunits. In situ hybridization using isoform-specific anti­
sense riboprobes showed that in control animals, there are moderate levels of mRNA for 
Na'" channel a-subunits N av i.2, NavI.S, and p-subunits p1 and p2. In diabetic animals, 
we observed a statistically significant (p<0.05) increase in mRNA levels for each of these 
four Na" channel subunits within the SON (Fig. 2.2). There was no change in sodium 
channel expression within the surrounding neuropil. Immunocytochemical observations 
using isoform-specific antibodies showed that there are parallel changes in protein for 
both of the a-subunits and the p2-subunit within the SON (Fig. 2.3).
Functional changes in diabetic MNCs. To determine whether the up-regulated mRNA 
and protein resulted in an increase in the number and/or density of functional channels 
inserted into the neuronal membrane, we acutely dissociated MNCs from control (n=5) 
and diabetic (n=5) animals and studied them using patch clamp electrophysiology. 
Control and diabetic MNCs both produced fast, TTX-sensitive sodium currents. The 
voltage dependence of activation and steady-state inactivation of the transient sodium
12
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current were similar for diabetic and control MNCs (Fig. 2.4A,B)- The time constant for 
inactivation (measured at 0 mV) was similar for MNCs from diabetic (x=.65±.03 ms, 
n=31) and control (x=.67±.03 ms, n=22) animals. However the peak transient current 
amplitude was 130% greater in MNCs isolated from the diabetic animals (Fig. 2.40; 
13.2±12.2 nA, control, n=23; 30.4±2.9 nA, diabetic, n=34; p<0.001). Since MNCs from 
diabetic animals showed an increased soma size (measured by cell capacitance; 
16.7±1.1 pF, control; vs. 20.0±0.9 pF, diabetic; p<0.05), peak current density (peak 
amplitude divided by cell capacitance) was also compared. Peak current density in 
diabetic MNCs was 65% greater (p<0.05) than in control animals (Fig. 2.4D).
Because persistent sodium currents are known to contribute to neuronal bursting 
(Crill, 1996; Parri and Crunelli, 1998; Taddese and Bean, 2002) and are increased in 
MNCs exposed to hyperosmolar conditions (Tanaka et al., 1999), we elicited persistent 
sodium currents by slow ramp depolarizations (233 mV/s) and compared them in control 
and diabetic MNCs (Fig. 2.4E). Both control and diabetic MNCs produced TTX-sensitive 
ramp currents that were activated at potentials close to threshold (-65 to -55 mV). The 
diabetic MNCs exhibited significantly larger ramp currents than control MNCs (218±29 
pA, control, n=21; 428+45 pA, diabetic, n=31; p<0.005). The ramp current density was 
-50% larger in the diabetic MNCs (21.5±2.0 pA/pF, n=31) than in control cells (14.5+2.5 
pA/pF, n=21, P<0.05) (Fig. 2.4D).
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Fig. 2.1. A. Streptozotocin-induced diabetes causes elevated serum osmolality. B. 
MNCs increase their production of vasopressin, as detected by vasopressin antibody 
immunoreactivity (left panel (VP) = control, right panel (VP*) = diabetic).
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Fig. 2.2. Sodium channel subunit mRNA transcripts are up-regulated In diabetic MNCs. 
A, Moderate levels of Nav1.2, Nav1.6, p1 and p2 were detectable In control SON (no *) 
and there was a significant up-regulatlon of each of these transcripts In the diabetic 
animals (*). The fields of control and diabetic tissue shown were digitally contrast- 
enhanced to qualitatively Illustrate the up-regulatlon of transcripts, but they do not 
Illustrate the quantitative magnitude of the changes. B, Optical Intensity measurements 
from unenhanced Images in the histogram provide quantitative comparisons between 
control (■ ) and diabetic (□ ) animals. Optical densities were normalized for each 
transcript to facilitate comparison of diabetic and control tissue. Error bars Indicate SEM, 
* = p<0.05.
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Fig, 2,3. Sodium channel subunit protein is up-regulated in diabetic MNCs. A, Moderate 
levels of Navi .2, Navi .6, and p2 were detectable in control SON (no *) and there was a 
significant up-regulation of each of these proteins in the diabetic animals (*). The fields 
of control and diabetic tissue shown were digitally contrast-enhanced to qualitatively 
illustrate the up-regulation of transcripts, but they do not illustrate the quantitative 
magnitude of the changes. B, Optical intensity measurements from unenhanced images 
in the histogram provide quantitative comparisons between control (■ ) and diabetic (□ ) 
animals. Optical densities were normalized for each channel to facilitate comparison of 
diabetic and control tissue. Error bars indicate SEM, * = P<0.05.
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Fig. 2.4. Comparison of sodium currents in control and diabetic MNCs. A, The 
normalized peak current-voltage relationship for control (■ ; MVk = -28.4+1.7 mV, n=16) 
and diabetic (O; V14 = -31.0±1.5 mV, n=28) MNCs are similar. B, Comparison of control 
(■ ; V72=-62.7±1 .2 mV, n=22) and diabetic (O; V72=-67.4±1.3 mV, n=32) MNC steady- 
state inactivation. Steady-state inactivation was measured with 500 ms inactivating 
prepulses. Cells were held at prepulse potentials over the range of -130 to -10 mV prior 
to a test pulse to 0 mV for 20 ms. Error bars indicate SEM. C, Family of traces from 
representative neurons acutely isolated from control (left panel) or diabetic (right panel) 
rats. The currents were elicited by 40 ms test pulses to various potentials from -80 to 40 
mV. Cells were held at -100 mV. D, The peak and ramp current densities (estimated by 
dividing the maximum currents by the cell capacitance) are larger in diabetic MNCs (□,
17
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n=34) than in control MNCs (H, n=23). Error bars indicate SEM, and the * indicates 
P<0.05. E, Representative ramp currents elicited in MNCs by slow voltage ramps (600 
ms voltage ramp extending from -100 to +40 mV) are shown.
2.5 DISCUSSION
Magnoceilular neurosecretory cells (MNCs) are responsible for the synthesis and 
controlled release of vasopressin. We have demonstrated that MNCs normally 
coexpress the Navl.2, N avi.6 , p i and p2 voltage-gated sodium cShannel subunits and 
that in experimental diabetes, the mRNA and protein levels for these sodium channel 
subunits are elevated. We have also shown that electrophysiological changes parallel 
these molecular changes.
Neuronal firing patterns are dependent on sodium currents, and persistent 
currents lower the threshold for firing and predispose neurons to fire spontaneously 
(Crill, 1996; Parri and Crunelli, 1998; Taddese and Bean, 2002). It is known that 
electrical activity, cAMP levels, and intracellular calcium influence sodium channel 
expression in excitable cells (Offord and Catterall, 1989; Sashihara et al., 1997), while 
activity-dependent phosphorylation state influences the functional properties of the 
channel (Cantrell and Catterall, 2001; Cukierman, 1996; Li et al., 1993). Consistent with 
increased transcription and translation of two sodium channel a-subunits and their 
insertion into the ceil membrane, we observed higher amplitudes and densities of two 
sodium currents (transient and persistent) in MNCs of diabetic rats, similar to the 
changes that accompany the transition of MNCs to the bursting state in salt-loaded rats 
(Tanaka et al., 1999). This would be expected to contribute to increased excitability and 
vasopressin release in diabetes.
18
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Diabetic nephropathy is thought to result from prolonged elevated levels of serum 
vasopressin (Ahloulay et al., 1999; Bardoux et al., 1999), which raise blood pressure and 
increase filtration demand to the kidneys (see Fig. 2.5). It has been demonstrated i) that 
the antidiuretic V2-receptor-dependent effects of vasopressin directly affect glomerular 
filtration rate and albumin excretion, and ii) that in STZ-injected vasopressin-deficient 
rats there is no hyperfiltration and decreased renal hypertrophy and albuminuria 
compared to controls (Bankir et al., 2001; Bouby et al., 1999). In this study we have 
shown that there is a link between the onset of experimental diabetes (which is 
associated with vasopressin release (Ahloulay et al., 1999; Bardoux et al., 1999)), and 
changes in sodium channel transcription and translation which result in the insertion of 
increased numbers of functional channels in the cell membrane of neurosecretory 
neurons within the hypothalamus. These changes in expression of sodium channels in 
the SON represent a previously undescribed change in the brain in experimental 
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Fig. 2.5. Chronic hyperglycemia induces changes in gene transcription in 
vasopressinergic MNCs of the hypothalamus and these changes, in turn, can contribute 
to the development of diabetic nephropathy.
Our results demonstrate up-regulation of sodium channel transcription, and 
insertion of increased numbers of functional sodium channels in the membranes of 
MNCs in experimental diabetes. We propose that, in untreated or under-treated 
diabetes, the SON attempts to correct osmolality and normalize blood pressure by 
persistent release of vasopressin, which requires sustained impulse activity. As 
discussed above, action potential activity in MNCs triggers the release of vasopressin, 
which over time irreversibly damages the microvasculature of the kidney and causes the 
changes characteristic of diabetic nephropathy. Identification of this change in the brain 
in experimental diabetes, and of the specific sodium channel subtypes associated with it, 
may suggest new therapeutic strategies for preventing or delaying the onset of vascular 
and renal complications of diabetes.
20
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CHAPTER 3
APOPTOSIS OF VASOPRESSINERGIC HYPOTHALAMIC 
NEURONS IN CHRONIC DIABETES MELLITUS
3.1 SUMMARY
The hyperosmolality associated with diabetes mellitus triggers an increase in 
neuronal activity and vasopressin production within magnoceilular neurosecretory cells 
of the hypothalamic supraoptic nucleus (SON). In this study, we examined the effect of 
chronic diabetes on the function and survival of these neurons. After 6 months, but not 6 
weeks, of streptozotocin (STZ)-induced diabetes, we observed an increase in the 
appearance of small hyperchromatic neurons, and a decrease in SON neuronal density. 
A sub-population of neurons within the SON at this time point demonstrated positive 
staining for cleaved caspase-3 and TUNEL, two markers of apoptosis. In addition, the 
number of vasopressin-positive neurons was decreased. Markers for apoptosis did not 
colocalize with vasopressin immunopositivity; this was probably due to a diabetes- 
induced degenerative process causing down-regulation of vasopressin expression 
and/or depletion of neuropeptide. Although the phenotypes of the apoptotic neurons 
were not identified, other SON neurons including oxytocin-producing neurons are 
unlikely to be affected by chronic hyperglycemia. Microglial hypertrophy and 
condensation was also observed in the 6 month diabetic SON. Although up-regulation of 
vasopressin production in response to acute hyperosmolality is adaptive, prolonged 
overstimulation of vasopressin-producing neurons in chronic diabetes results in 
neurodegeneration and apoptosis.
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3.2 INTRODUCTION
The diabetic state results in an increase in plasma vasopressin levels, primarily 
as a result of hyperglycemia-induced hyperosmolality. This effect is observed in humans 
with diabetes mellitus and in experimental models of diabetes (Bankir et al., 2001; 
Brooks et al., 1989; Van Itallie and Fernstrom, 1982). While elevated vasopressin levels 
may be adaptive in the short term, there is evidence suggesting that prolonged elevated 
levels of vasopressin can cause chronic renal hyperfiltration, albuminuria, and 
hypertrophy, and ultimately contribute to diabetic nephropathy and renal failure (Ahloulay 
et al., 1999; Bardoux et al., 1999).
Vasopressin is synthesized in magnoceilular neurosecretory cells (MNCs) within 
the supraoptic nucleus (SON) of the hypothalamus, and released from the neuropituitary 
in response to elevated plasma osmotic pressure. In diabetes, there is an increased 
demand on these neurons to produce enough vasopressin to maintain euvolemia and 
minimize fluid shifts between intracellular and extracellular environments.
Experimental evidence suggests that chronic overactivation of these neurons 
may have adverse effects on their survival. Ultrastructural studies first demonstrated that 
in streptozotocin (STZ)-induced diabetes there is an age-dependent progressive 
degeneration of SON neurons including the appearance of abnormal somata, dendrites, 
axonal profiles, and cytoplasmic vacuoles (Dheen et al., 1994a). This same study 
reported a significant increase in mean cross-sectional area and cross-sectional nuclear 
area of diabetic SON neurons compared to controls (Dheen et al., 1994a). Nuclear and 
somal hypertrophy is suggestive of increased mRNA and protein synthesis, which 
reflects the increased demand for, and production of, vasopressin in diabetic MNCs 
(Crespo et al., 1990). While the diabetic SON is indeed characterized by hypertrophic 
neurons, Luo et al. (2002) recently observed that in addition, shrunken and 
hyperchromatic neurons are also present.
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Changes in the transcription of several genes in diabetic SON neurons have 
been examined. After 4 months of STZ-induced diabetes, vasopressin levels in SON 
neurons remain elevated compared to controls, but there is less up-regulation compared 
to earlier time points (Luo et a!., 2002), suggesting that in chronic diabetes, a functional 
insufficiency of vasopressin production may develop. The expression of voltage-gated 
sodium channels Nav1.2 and Nav1.6, which support the bursts of action potentials that 
release vasopressin, is up-regulated in diabetic SON neurons (Klein et al., 2002). 
Likewise, the glutamate receptor NMDAR and neuronal nitric oxide synthase (nNOS), 
which plays a role in the modulation of secretion of vasopressin, are also up-regulated in 
diabetic SON neurons (Kadowaki et al., 1994; Luo et al., 2002; Serino et al., 1998). In 
these neurons, NMDAR and nNOS overactivation may be excitotoxic and result in 
degeneration or apoptosis (Brecht et al., 2001). Following STZ-induced diabetes, 
neuronal apoptosis has in fact been demonstrated in hippocampal neurons (Li et al.,
2002) and retinal ganglion cells (Barber et al., 1998; Zeng et al., 2000).
In the present study we asked whether chronic STZ-induced diabetes leads to 
apoptotic cell death in vasopressinergic neurons of the SON. We report here that in 
chronic STZ-induced diabetes, there is increased expression of activated caspase-3 and 
markers of DNA degradation within SON neurons, compared to age-matched 
normoglycemic controls. These changes were evident after 6 months of diabetes, but 
not after 6 weeks of diabetes. We propose that long-term neuronal overstimulation in 
chronic diabetes induces a heterogenous response in the SON; some neurons 
degenerate and/or undergo apoptosis while others continue to produce and secrete 
vasopressin.
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3.3 MATERIALS AND METHODS
Induction o f diabetes. Adult male Sprague-Dawley rats (225-250g) were injected with
streptozotocin (STZ, 60 mg/kg Lp., Sigma, St. Louis, MO). Animals were housed in a 12 
h light-dark cycle with free access to water and food. Plasma glucose (Encore 
Glucometer, Miles inc., Elkhart, IN) was measured at 6 weeks and 6 months post- 
injection and compared to control rats injected with saline. In total, 18 animals were 
used: 5 diabetic and 4 control rats at 6 weeks, and 5 diabetic and 4 control rats at 6 
months. All experimental manipulations were carried out in accordance with National 
Institutes of Health guidelines for the care and use of laboratory animals, and all animal 
protocols were approved by the Yale University Institutional Animal Care and Use 
Committee.
Neuronal morphology. All rats were anesthetized with ketamine/xylazine (80/5 mg/kg 
i.p.) and then underwent intracardiac perfusion with 0.01 M PBS followed by a 4% 
solution of cold buffered paraformaldehyde. Brains were removed, postfixed and 
cryoprotected in 30% sucrose in 1 M phosphate buffer solution (PBS), and coronal 
cryosections (10 pm) of cortex containing the SON were cut. Sections were stained with 
Cresyl Violet (Sigma). Neuronal area and diameter were determined by outlining 
individual neurons whose nuclei were visible in the plane of section, using IPLab vS.O 
Image Processing software (Scanalytics, Fairfax, VA). Counts of neurons within the SON 
were performed by arbitrarily selecting an area within the SON and averaging multiple 
counts (fj=6) of neurons from the 6 week and 6 month control and diabetic animals.
Immunocytochemistry. Sections were incubated in blocking solution (5% normal goat 
serum and 1% BSA in PBS) containing 0.1% Triton X-100 and 0.02% sodium azide at
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room temperature for 30 min, then incubated with antibodies to either vasopressin 
(1:1000, Oncogene Research Products, San Diego, CA), cleaved caspase-3 (1:50, Cell 
Signaling Technology, Beverly, MA), glial fibrillary acidic protein (GFAP) (1:50, 
Chemicon, Temecula, CA), or OX-42 (C DIIb/c) (1:50, BD Biosciences, Franklin Lakes, 
NJ) overnight at 4 °C. Sections reacted with the caspase-3 antibody were washed in 
PBS and incubated with biotinylated goat anti-rabbit serum (1:1000, Sigma) in blocking 
solution for 3 hours, then washed in PBS and incubated in ExtrAvidin-HRP (1:1000, 
Sigma) in blocking solution for 3 hours. These sections were then washed again in PBS 
and exposed to heavy metal enhanced 3,3’-diaminobenzidine*4HCI in IX  peroxide 
substrate buffer (Pierce, Rockford, IL) for 7 min, washed in PBS, and mounted with 
Aqua-Polymount (Polysciences, Warrington, PA). Alternatively, for double labeling 
experiments utilizing fluorescent labels, goat anti-rabbit lgG-Cy3 (1:2000, Amersham, 
Piscataway, NJ) and goat anti-mouse lgG-Cy2 (1:1000, Molecular Probes, Eugene, OR) 
secondary antibodies were used. Vasopressin signal was detected using rhodamine 
epifluorescence illumination (emission wavelength 570-620 nm) and GFAP and OX-42 
signals were detected using fluorescein epifluorescence illumination (emission 
wavelength 516-565 nm).
For detection of terminal d-UTP nick end labeling (TUNEL) of genomic DNA, 10 
pm coronal sections of SON that had been previously reacted with vasopressin antibody 
were incubated sequentially in: PBS, 3% H2O2 in methanol for 10 min., PBS, 0.1% Triton 
X-100 in freshly prepared 0.1% sodium citrate for 15 min., PBS, and a mix of 100 ml 
label solution (containing fluorescein-dUTP) and 400 ml enzyme solution (containing 
terminal deoxynucleotidyl transferase, TdT; In Situ Cell Death Detection Kit, Roche, 
Indianapolis, IN), at room temperature for 3 hours.
Following vasopressin and TUNEL localization, sections were reacted with the 
nuclear stain Hoechst 33342 (10 pg/ml. Molecular Probes) for 10 min, washed with PBS,
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and mounted with Aqua-Polymount. TUNEL positive neurons were detected using 
fluorescein epifluorescence illumination. Hoechst 33342 signal was observed using 
ultraviolet (UV) fluorescence illumination. To evaluate colocalization of staining, 
rhodamine-, fluorescein-, and UV-filtered images were merged using Adobe Photoshop 
v5.5.
Data Analysis. Quantitative microdensitometry was performed with a Nikon Eclipse 
E800 light microscope (20X objective) using IPLab software (Scanalytics). Signal 
intensities were determined by outlining individual neurons, and IPLab integrated 
densitometry functions were used to calculate mean signal intensities for the selected 
areas. Only neurons with distinct borders and visible nuclei in the plane of section were 
counted. Immunopositive neurons were defined as signal greater than 2X background 
levels and specifically localized within the margins of the neuronal plasma membrane. 
Immunopositive neurons were counted as a fraction of total neurons in the SON. TUNEL 
positive neurons were also compared to counts of vasopressin positive neurons in the 
SON. Data from neuron counting procedures was analyzed using one-way ANOVA with 
post-hoc multiple comparison analysis. Microglial morphology was quantified by 
comparing the maximum microglial cell diameter including dendritic processes in control 
and diabetic animals (Kreutzberg, 1996), and analyzed using a nonpaired t-test. An 
alpha level of 0.05 was used as a threshold for statistical significance. All data is 
presented as mean ± SE.
3.4 RESULTS
Morphological changes occur in diabetic MNCs. All animals injected with 
streptozotocin (STZ) developed hyperglycemia (>250 pg/dl) compared to control animals 
injected with saline. After either 6 weeks or 6 months, tissue sections of supraoptic
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nucleus (SON) from control and diabetic animals were stained with Cresyl Violet (NissI) 
to examine changes in cellular morphology. In control animals at 6 weeks and 6 months, 
there was relatively little variation in cell size, with the majority of neurons in the 10-15 
fim range (Fig. 3.1A,A’,C,C’). In contrast, after 6 weeks of diabetes, there was a change 
in size distribution of magnoceilular neurosecretory cells (MNCs) such that a greater 
proportion of neurons were larger (15-25 pm) (Fig. 3.1B,B’). After 6 months of diabetes, 
an even greater heterogeneity of SON size was observed: there was a similar trend 
toward larger neurons, but in addition, there was an increased proportion of smaller 
neurons (<10 pm) (Fig. 3.1D,D’), which were not seen in controls or the 6 week diabetic 
SON. The larger neurons showed nuclear and Golgi distention and cytoplasmic swelling 
and vacuolization (arrows), while the smaller neurons tended to be hyperchromatic 
(arrow heads).
Counts of neurons revealed no significant difference between 6 week and 6 
month control SONs, or between 6 week diabetic and 6 week control SONs. In the 6 
month diabetic animals, neuronal density was significantly decreased, by 34.5% 
compared to 6 month controls (Fig. 3.IE, *=p<0.05).
Cleaved caspase-3 expression is up-regulated in the chronically diabetic SON.
Cleaved caspase-3 is the activated form of caspase-3, a critical effector of apoptosis 
(Cohen, 1997). Immunocytochemistry using an antibody directed against cleaved 
caspase-3 revealed low levels of caspase-3 immunoreactivity in neurons from control 
animals at 6 weeks and 6 months, and from diabetic animals at 6 weeks (Fig. 3.2A-C). 
Six month diabetic animals demonstrated a large up-regulation of cleaved caspase-3 
expression, which was visible in the cytoplasmic compartment of the neurons (Fig. 
3.2D). 28% of SON neurons in the 6 month diabetic group were immunopositive.
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compared to approximately 5% in the other groups (Fig. 3.2E, *=p<0.05). In general, the 
level of immunostaining of neurons in the 6 week diabetic group (Fig. 3.2B) was greater 
compared to the controls (Fig. 3.2A,C), but many of these moderately stained neurons 
(Fig. 3.2B) were not above the threshold for inclusion in the immunopositive group.
DNA fragmentation occurs in the chronically diabetic SON. Having demonstrated an 
up-regulation of caspase-3 in the 6 month diabetic SON, we sought to confirm these 
findings using an additional marker of apoptosis. The TUNEL assay was used to identify 
DNA strand breaks, which occur in apoptotic neurons as a result of cleavage of genomic 
DNA. At 6 months, TUNEL positive neurons were not seen in control MNCs (Fig. 3.3B), 
but were clearly visible in neurons in the diabetic SON (Fig. 3.3E, arrows). Fig. 3.3A and 
D are phase-contrasted images of the cells shown in B and E. Fig. 3.30 and F are 
overlays of 3.3A and B, and 3.3D and E, respectively. TUNEL positive neurons were 
detected extremely infrequently in the 6 week control, 6 week diabetic, and 6 month 
control SON, and were significantly increased in 6 month diabetic SON (Fig. 3.4, 
*=p<0.05).
TUNEL and vasopressin are not colocallzed in the chronically diabetic SON. It is
well established that vasopressin is up-regulated in diabetic MNCs, and it has been 
hypothesized that neuronal overactivation due to chronic hyperosmotic stimulation may 
lead to neuronal degeneration and apoptosis. Table 3.1 shows a quantification of 
neuronal phenotype in control and diabetic animals after 6 weeks and 6 months of 
diabetes. These measurements indicate that (1) the percent of vasopressin-positive 
neurons in increased in 6 week diabetic animals; (2) the number of vasopressin-negative 
neurons in decreased in 6 week and 6 month diabetic animals; (3) the number of 
vasopressin-positive neurons is decreased in 6 month diabetic animals, and (4) the
28
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
number of total SON neurons in decreased in 6 month animals. We then attempted to 
correlate vasopressin immunoreactivity with TUNEL staining in the 6 month diabetic 
animals. Vasopressin immunopositive neurons are clearly visible in Fig. 3.5A (arrow 
heads). TUNEL positive neurons can be seen in Fig. 3.5B (arrows). Hoechst 33342 
staining of nuclei is shown in Fig. 3.5C. The vasopressin immunopositive neurons had 
normal-appearing nuclei (Fig. 3.5C, arrow heads), while the TUNEL positive neurons 
showed condensed, pyknotic, and irregular nuclei (Fig. 3.5C, arrows). Overlay of Fig. 
3.5A-C, as seen in Fig, 3.5D, demonstrated that after 6 months of diabetes, vasopressin 
positive neurons do not exhibit overlap with TUNEL positive neurons. This result was 
quantified in Fig. 3.4. The apoptotic neurons appeared to comprise a separate 
population from the presumably functional vasopressin-producing neurons.
Microglial activity is enhanced in the diabetic SON. Because neuronal density in the 
6 month diabetic SON was decreased (Fig. 3.1E), we examined the possibility that 
microgliosis and/or astrocytosis occurs in conjunction with neuronal degeneration and 
apoptosis. Vasopressin and either OX-42 (a marker for activated microglia) or GFAP (a 
marker for reactive astrocytes) were detected simultaneously in tissue slices containing 
the SON, using fluorescence microscopy. At 6 weeks, the SON from both control and 
diabetic animals showed similar staining for OX-42 (Fig. 3.6A,B), and GFAP (Fig. 
3.6A’,B’). At 6 months, GFAP staining in both the control and diabetic SON was 
modestly increased compared to 6 weeks, and GFAP staining in control and diabetic 
SON appeared similar at this time point (Fig. 3.6A’,B’,C’,D’). In contrast, OX-42 staining 
in the 6 month diabetic SON showed hypertrophic and condensed microglia (Fig. 3.6D, 
arrows), which differed from the normal branched dendritic pattern seen in controls (Fig. 
3.60, arrow heads). The maximum diameter of microglial cells including their dendritic 
processes was quantified (Fig. 3.6E). Six month diabetic animals demonstrated
29
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truncated processes and reduced maximum cell diameter suggesting microglial 
activation in these animals.
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Fig. 3.1. Morphological changes of diabetic neurons. Cresyl violet staining of sections of 
supraoptic nucleus from 6 week control (A) and diabetic (B), and 6 month control (C) 
and diabetic (D) animals. Arrows in B and D indicate hypertrophic neurons; arrow heads 
in D indicate shrunken, hyperchromatic neurons. Size frequency histograms 
corresponding to A-D are shown in A’-D’ . Neuronal density is quantified in E. Scale bar 
in A = 50 |im. Data are plotted as mean ± SE, * = p <  0.05.
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Fig. 3.2. Cleaved caspase-3 Immunoreactivity in sections of supraoptic nucleus from 6 
week control (A) and diabetic (B), and 6 montfi control (C) and diabetic (D) animals. 
Images were converted to greyscale and identically digitally contrast-enhanced to 
qualitatively illustrate differences in immunostaining. Quantitative microdensitometry of 
unenhanced images was used to obtain data shown in E. Neurons defined as 
immunopositive demonstrated signal greater than 2X background levels with staining 
specifically localized to within the margins of the plasma membrane. Scale bar in (A) = 
50 pm. Data are plotted as mean ± SE, * = p < 0.05.
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Fig. 3.3. TUNEL assay for apoptosis-related DNA fragmentation. Pfiase-contrast Images 
of 6 month control (A) and diabetic (D) supraoptic nucleus are shown to identify neuronal 
boundaries. TUNEL staining Is shown for 6 month control (B) and diabetic (E) sections. 
C Is an overlay of A and B, and F is an overlay of D and E. Positive TUNEL staining (E, 
arrows) occurs within neuronal boundaries (F, arrows), and Is not detected In control 
SON neurons (C, arrow heads). Scale bar In A = 50 pm. Data are plotted as mean ± SE, 
* = p <  0.05.
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Fig. 3.4. Quantification of TUNEL positive neurons within the supraoptic nucleus of 6 
week and 6 month control and diabetic animals (white bars). TUNEL positive neurons 
demonstrated signal greater than 2X background levels. The percentage of neurons that 
were both TUNEL positive and vasopressin immunopositive is shown (grey bars). Data 
are plotted as mean ± SE, * = p < 0.05.
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Fig. 3.5. Vasopressin (VP), TUNEL, and Hoechst 33342 (H33342) images from 6 month 
diabetic supraoptic nucleus. Vasopressin immunopositive neurons are clearly visible in A 
(arrow heads). TUNEL positive cells are visible in B (arrows). Hoechst 33342 nuclear 
stain is shown in C. Arrow heads in C showing low intensity nuclear staining correspond 
to vasopressin immunopositive neurons in A. Arrows in C showing pyknotic, condensed, 
and hyperchromatic nuclei correspond to TUNEL positive cells in B. Overlay of A, B, and 
C is shown in D; arrow heads correspond to vasopressin immunopositive neurons, 
arrows correspond to TUNEL positive neurons. Scale bar in A = 50 pm.
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Fig. 3.6. Glial response to chronic diabetes. Sections of supraoptic nucleus were stained 
with vasopressin (red) and either OX-42 (green, left panels. A-D) or GFAP (green, right 
panels, A ’-D’). A and A’ are from 6 week controls; B and B’ are from 6 week diabetics; C 
and C’ are from 6 month controls; and D and D’ are from 6 month diabetics. Arrow heads 
in C show normal branched dendritic microglial morphology. Arrows in D show 
hypertrophic and condensed microglia. Insets in A-D show greater detail of microglial 
cells. The histogram in E is a quantification of changes in microglial morphology. Six 
month diabetic animals demonstrate reduced maximum cell diameter suggesting 
microglial activation. Data are plotted as mean ± SE, * = p < 0.05. Scale bar in A = 50
|Lim.
Table 3.1. Quantification of SON neuronal phenotype. Data is shown as mean ± SE, 
p <0.05; significant difference from corresponding control group.
VP+ VP- Total
6 week control 20.0 ± 5.5 (29.3%) 48.3 ± 3.5 (70.7%) 68.3 ± 5.5 (100.0%)
6 week diabetic 24.3 ±3.3 (40.1%*) 36.3 ± 2.6* (59.9%*) 60.7 ±3.8 (100.0%)
6 month control 20.0 ± 2,0 (29.9%) 46.6 ± 5.5 (70.1%) 66.7 ± 5.4 (100.0%)
6 month diabetic 14.0 + 0.8* (27.5%) 37.0 ± 1.5* (72.5%) 51.0 ±2.2* (100.0%)
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3.5 DISCUSSION
The hyperosmolality associated with diabetes mellitus triggers both structural and 
metabolic changes within magnoceilular neurosecretory cells (MNCs) of the 
hypothalamic supraoptic nucleus (SON). These changes occur, at least in part, as a 
result of neuronal activation and the demand for increased production and secretion of 
vasopressin. It is well established that chronic neuronal overactivation can lead, by a 
variety of mechanisms including nNOS activation and progressive intracellular calcium 
accumulation, to neuronal degeneration and apoptosis (Brecht et al.. 2001; Dawson et 
al., 1991). In the present study, we asked the question of whether apoptosis occurs 
among vasopressin-producing neurons after prolonged diabetes. We utilized 
morphometric and immunocytochemical criteria to examine diabetic SON neurons.
Although we did not label SON neurons that produce and secrete oxytocin, it is 
unlikely that these neurons are affected by experimental diabetes. Our use of male 
animals also limited gender effects on oxytocin secretion. Assuming the oxytocin 
neurons do not become overactivated or undergo apoptosis as a result of chronic 
diabetes, then our estimates of vasopressin neuron loss in diabetes are, if anything, an 
underestimate of the actual percentage of vasopressin neurons lost in chronic diabetes.
Our principal findings are that after 6 months of diabetes: (1) small 
hyperchromatic neurons with condensed and irregular somal and nuclear profiles are 
present in addition to hypertrophic neurons; (2) neuronal density is significantly 
decreased in the SON; (3) cleaved caspase-3 immunoreactivity is up-regulated in a sub­
population of SON neurons; (4) DNA fragmentation is detectable in some SON neurons; 
(5) the number of vasopressin-positive neurons is decreased; (6) TUNEL positive 
neurons do not colocalize with vasopressin-producing neurons; and (7) microglial 
hypertrophy and condensation is evident. Identification of neuronal apoptosis in the SON 
after chronic diabetes is an important finding, as tight regulation of plasma osmolality is a
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critical physiologic requisite, without which dysregulation of fluid homeostasis will occur.
Analysis of neuronal area and diameter by Cresyl Violet staining provided the 
first suggestion of neuronal degeneration and apoptosis in this study. The 6 month 
diabetic SON contained a unique population of neurons that were <10 pm in diameter 
and appeared hyperchromatic. Neuronal density was also decreased in the 6 month 
diabetic SON. We reasoned that cell death by an apoptotic mechanism might account 
for these changes, and assayed for several hallmarks of apoptosis to test this 
hypothesis.
Caspase-3 is an important regulator of apoptosis, and its proteolytically cleaved 
form is known to be up-regulated in neurons undergoing apoptosis (Kermer et al., 1999; 
Srinivasan et al., 1998). In our study, cleaved caspase-3 immunoreactivity was strongly 
up-regulated in 6 month diabetic SON neurons (Fig. 3.2). The interval over which 
cleaved caspase-3 yields an immunopositive signal is thought to span the entire active 
process of neuronal degeneration, and thus may include much of the time course of 
apoptosis (Brecht et al., 2001). Therefore, the percent of immunopositive neurons 
reported in Fig. 3.2E may not be an accurate measure of the incidence of apoptosis, and 
almost certainly represents an overestimate of the rate of neuronal death at any given 
time point. Morphological assessment of neurons expressing cleaved caspase-3 might 
be helpful in determining how far along the apoptotic process individual neurons are.
The TUNEL assay is a useful marker for apoptosis-related genomic DNA 
fragmentation (Gavrieli et al., 1992; Migheli et al., 1995) and was used in conjunction 
with caspase-3 immunoreactivity in this study as a second marker of apoptosis. DNA 
fragmentation results from oxidative DNA damage and is a final irreversible step of the 
apoptotic process (Brecht et al., 2001). Neurons only transiently show positive TUNEL 
staining and therefore TUNEL positivity may be a more accurate reflection of the 
incidence of neuronal death compared to caspase-3 immunoreactivity (Duan et al.,
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2003). Detection of TUNEL positivity, however, is challenging. Whereas 
immunocytochemical procedures benefit from signal-boosting amplification steps such 
as the biotin-avidin-HRP process, the TUNEL reaction is a one-step procedure. In our 
study, it was necessary to increase the gain (identically for diabetic and control tissue 
slices) on the microscopic images in order to detect and compare TUNEL positive and 
TUNEL negative neurons (Fig. 3.3). It is possible, as a result of this manipulation, that 
our false positive rate was increased, and that the percentages of TUNEL positive 
neurons shown in Fig. 3.4 are in fact an overestimate. In order to more accurately 
confirm TUNEL positivity, we used Hoechst 33342 nuclear staining as a means of 
colocalization with the TUNEL signal (Fig. 3.5). TUNEL positive neurons showed 
pyknotic and irregular nuclei, which are characteristic of apoptotic cell death (Fig. 3.5C, 
arrows).
In addition to apoptosis, the decreased neuronal density observed in the 
chronically diabetic SON could also be due to gliosis, and reflect a relative dilution of 
neurons by proliferating astrocytes and microglia. Peri-neuronal astrocytes can modulate 
hormone release by altering their processes. In rats subjected to dehydration (and 
consequent hyperosmolality), a gross retraction of astrocytic processes has been 
reported in the SON, which is reversible with hydration (Hawrylak et al., 1998). Detailed 
ultrastructurai analysis of this phenomenon reveals that in dehydrated rats 
neurovascular astrocytic contacts expand while neuroglial contacts decrease in size 
(Miyata et al., 2001; Miyata and Hatton, 2002). The increase in terminal-capillary 
contacts provides a route for increased neuropeptide release.
Like the dehydrated state, chronic diabetes subjects the SON to a hyperosmotic 
environment, and triggers an increase in vasopressin production and release. 
Immunocytochemical experiments have shown astrocyte retraction and condensation in 
the diabetic SON (Luo et al., 2002). In contrast to this response to dehydration,
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astrocytes can also hypertrophy following neuronal injury and degeneration. GFAP 
immunoreactivity in the chronically diabetic SON may therefore reflect multiple (and 
possibly opposing) factors, and in this study, the pattern of GFAP staining in diabetic 
SON was not distinguishable from age-matched control SON.
Previous work has shown that microglia within the SON hypertrophy and shorten 
their processes in response to diabetes (Luo et al., 2002). In the present study, this 
effect was clearly evident after 6 months of diabetes. Microgliosis and microglial 
activation can occur in response to a variety of stimuli including neuronal ischemia, 
inflammation, infection, neoplasia, and neurodegeneration (Kreutzberg, 1996). 
Neurotoxic overactivation and apoptosis were the likely triggers for microglial 
proliferation, condensation, and truncation of processes as seen in Fig. 3.6.
Several important questions are raised by this study. First, why were the 
apoptotic changes not seen at 6 weeks? Because there is no time point at which acute 
diabetes is delineated from chronic diabetes, it is not possible to conclude that the onset 
of neuronal apoptosis corresponds to chronic diabetes. Instead, the detection of 
apoptosis after 6 months of diabetes is indicative of a dynamic process of accumulating 
neuronal injury which is likely to be present at lower levels, in this case, largely 
indistinguishable from controls, at the 6 week time point.
Second, as shown in Fig. 3.4, the rate of vasopressin and TUNEL overlap is very 
low in the diabetic SON. A possible explanation for this is that overstimulated neurons 
reach a degeneration threshold, where normal function (vasopressin production) is 
attenuated and the irreversible steps of apoptosis (positive TUNEL signal) begin. The 
few neurons that demonstrated positive labeling for both vasopressin and TUNEL may 
have been transitioning between functioning and degenerating states. The molecular 
changes that account for this transition may result from alterations in intracellular 
calcium homeostasis, secondary to neuronal overstimulation. Elevated intracellular
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calcium levels are known to exist within many diabetic tissues (Levy et al., 1994). 
Diabetic hippocampal neurons, for example, undergo a slow progressive dysregulation 
of calcium homeostasis, which at first alters their synaptic function (Biessels et al., 2002; 
Kama! et al., 1999), and can eventually lead to apoptosis (Li et al., 2002).
Diabetes remains a chronic progressive disease with significant vascular and 
neurologic complications (Biessels et al., 1994; Donnelly et al., 2000; McCall, 1992). 
While chronically up-regulated circulating levels of vasopressin can cause glomerular 
damage within the kidney, we have shown here that chronically overstimulated 
vasopressin-producing neurons within the SON undergo apoptosis. While up-regulation 
of vasopressin is adaptive in an acute hyperosmotic state, our results suggest that 
chronic hyperosmolality may result in a pathologic sequence of neurotoxic events which 
ultimately lead to neuronal loss.
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CHAPTER 4
PATTERNED ELECTRICAL ACTIVITY MODULATES SODIUM
CHANNEL EXPRESSION IN SENSORY NEURONS
4.1 SUMMARY
Peripheral nerve injury induces changes in the level of gene expression for 
sodium channels Nav1.3, Nav1.8, and Nav1.9 within dorsal root ganglion (DRG) 
neurons, which may contribute to the development of hyperexcitability, ectopic neuronal 
discharge, and neuropathic pain. The mechanism for this change in sodium channel 
expression is unclear. Decreased availability of neurotrophic factors following axotomy 
contributes to these changes in gene transcription, but the question of whether changes 
in intrinsic neuronal activity levels alone can trigger changes in the expression of these 
sodium channels has not been addressed. To examine this question, I carried out 
experiments in which the effect of electrical stimulation on the expression of Navi.3, 
Navi.8, and N avi.9 was examined using cultured embryonic mouse sensory neurons 
under conditions in which NGF was not limiting. Expression of Navi .3 was not 
significantly changed following stimulation. In contrast, we observed activity-dependent 
down-regulation of Navi .8 and Navi .9 mRNA and protein levels following stimulation, as 
demonstrated by quantitative PCR and immunocytochemistry. These results show that a 
change in neuronal activity can alter the expression of sodium channel genes in a 
subtype-specific manner, via a mechanism independent from NGF withdrawal.
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4.2 INTRODUCTION
Action potential generation within neurons is dependent on the activity of voltage- 
gated sodium channels (VGSCs). At least nine VGSC genes are expressed throughout 
the nervous system, each with different expression patterns and functional 
characteristics (Catterall, 2000; Goldin et al., 2000). The precise combination of 
channels in a neuronal membrane influences its excitability, and injury-induced 
alterations in the expression of VGSCs can lead to ectopic or spontaneous firing, 
thereby contributing to hyperalgesia and allodynia (Cummins and Waxman, 1997; 
Waxman et al., 2000). Because of the importance of sodium channels in action potential 
generation, and the injury-induced changes in axonal firing, it is difficult to determine 
whether changes in sodium channel expression are triggered by the abnormal axonal 
firing patterns, or rather depend entirely on activity-independent means of regulation, 
such as a response to changing growth factor levels.
Dorsal root ganglia (DRG) sensory neurons express multiple VGSC genes (Black 
et al., 1996; Caffrey et al., 1992; Sleeper et al., 2000). In addition to tetrodotoxin (TTX)- 
sensitive sodium channels, DRG neurons produce two unique TTX-resistant channels, 
N av i.8 (SNS/PN3) and Navi.9 (NaN), which are preferentially expressed in small 
nociceptive sensory neurons (Akopian et al., 1996; Dib-Hajj et al., 1998a; Dib-Hajj et al., 
1999a; Sangameswaran et al., 1996).
The maintenance of expression of N avi.8 and N avi.9, and of TTX-sensitive 
sodium channel N avi.3, in DRG neurons is dependent on the presence of neurotrophic 
growth factors, in vitro and in vivo studies have demonstrated a down-regulation of 
N av i.8 and N avi.9 and an up-regulation of N avi.3 following withdrawal of NGF and 
GDNF (Black et al., 1999a; Boucher et al., 2000; Cummins et al., 2001; Fjell et al., 
1999b) and axotomy (Dib-Hajj et al., 1998a; Sleeper et al., 2000; Waxman et al., 1994). 
Exogenous administration of specific growth factors can rescue the expression of
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Nav1.8 and Nav1.9 within axotomized DRG neurons (Boucher et a!., 2000; Cummins et 
al., 2001; Dib-Hajj et a!., 1998b; Fjeil et al., 1999a; Leffler et al., 2002).
While changes in neurotrophic growth factor availability can alter sodium channel 
expression, neurons can also adjust their gain and excitability by modulating sodium 
channel expression to adapt to, or react to, new input environments or new functional 
requirements. Evidence from a number of laboratories suggests that neurons can adjust 
their responsiveness by altering the number or kinetics of sodium channels In their 
membranes in order to electrically encode the changing range of stimulation to which 
they are exposed (Desal et al., 1999; Tanaka et al., 1999). It Is not known whether 
Impulse activity can regulate sodium channel expression in DRG neurons, although 
electrical stimulation has been shown to regulate the expression of voltage-gated 
calcium channels in DRG neurons (Li et al., 1996) and TTX-sensltlve sodium channels in 
skeletal myocytes (Brodle et al., 1989; Offord and Catterall, 1989; Sherman and 
Catterall, 1984).
In this study, we asked whether the expression of sodium channels N avi.3, 
N avi.8 and N av i.9 changes In cultured mouse sensory neurons as a result of patterned 
electrical stimulation. Because growth factors can affect sodium channel expression 
(Cummins et al., 2001; Dib-Hajj et al., 1998b; Fjell et al., 1999a) and stimulation can 
trigger release of growth factors (Balkowlec and Katz, 2000, 2002), we attempted to 
isolate the effect of activity on sodium channel expression independent of growth factor 
effects by supplying non-limiting amounts of NGF (50 ng/mL). Immunocytochemistry and 
quantitative PCR were used to identify changes in expression of mRNA and protein for 
N avi.3, Navi.8 and N av i.9.
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4.3 MATERIALS AND METHODS
Cell Culture. DRG neurons from E13.5 day fetal mice were dissociated in 0.125% 
trypsin and placed into culture media containing 5% horse serum and 50 ng/m l NGF as 
previously described (Fields et al., 1997). Provision of 50 ng/mL NGF to both stimulated 
and non-stimulated cultures insured that all neurons were exposed to a high level of 
NGF. For control experiments demonstrating the effect of NGF withdrawal on the 
expression of Navi .3, Navi .8 and Navi .9, media without NGF was used during the 5- 
day period of testing. DRG neurons (125,000 cells per side compartment) were plated in 
the two side compartments of a 3-multicompartment culture chamber (Campenot, 1977; 
Fields et al., 1990) and incubated in humidified 10% CO2  at 37 °C. Shallow parallel 
scratches (20-25 per plate) in the collagen-coated plastic culture dish helped direct 
neurite outgrowth from the side compartments into the central compartment. Mitosis of 
non-neuronal cells was inhibited by adding 13 pM FUDR applied one day after plating. 
Half of the volume of culture medium was changed every two days. All experimental 
manipulations were carried out in accordance with NIH guidelines for the care and use of 
laboratory animals, and all animal protocols were approved by the NIH Institutional 
Animal Care and Use Committee.
In Vitro Electrical Stimulation. DRG neurons were maintained in culture for 3 weeks 
prior to electrical stimulation. Culture chambers were randomly assigned to a control 
(non-stimulated) group and a stimulated group. Extracellular stimulation applied across 
the barrier between the side compartments and central compartment, which was 
sufficient to initiate action potentials in the neurons (Fields et al., 1992), was delivered by 
field electrodes using 5 V, 200 ps biphasic pulses. The stimulation pattern used was as 
follows: 10 Hz pulses lasting 0.5 s every 8 seconds, 12 hours per day for 5 days. This
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stimulation pattern results in increased neuronal firing frequency and activation 
compared to non-stimulated neurons, and has been previously shown to alter calcium 
currents (Li et al., 1996). In initial studies, a stimulation pattern of 10 Hz pulses lasting
0.5 s every 2 seconds, 12 hours per day for 40 hours, induced a significant down- 
regulation of Navi .8 and Navi .9 mRNA, but no change in protein. Since the half-life of a 
sodium channel is estimated to be approximately 1-2 days (Monjaraz et al., 2000; 
Ritchie, 1988; Schmidt and Catterall, 1986; Waechter et al., 1983), we decided to 
increase the stimulation time to 5 days in order to allow sufficient time for stimulation- 
dependent changes in protein levels to be detected.
Immunocytochemistry. Cultures were washed in PBS and fixed for 10 minutes in 2% 
paraformaldehyde solution. After additional washes with PBS, neurons were incubated 
in blocking solution (5% normal goat serum and 1% BSA in PBS) containing 0.1% Triton 
X-100 and 0.02% sodium azide at room temperature for 30 min, then incubated with 
isoform-specific polyclonal antibodies to Na'" channel a-subunits N avi.3 (residues 511- 
524, 1.19 pg/mL (Mains et al., 2002)), Navi .8 (residues 1041-1062, 1.80 pg/mL (Black et 
al., 1999b)), and N avi.9 (residues 1748-1765, 2.00 pg/mL (Fjell et al., 2000)), overnight 
at 4 °C. Neurons were washed in PBS and incubated with goat anti-rabbit lgG-Cy3 
(1:2000, Amersham Biosciences, Piscataway, NJ) in blocking solution for 3 hours, then 
washed again in PBS and mounted with Aqua Poly/Mount (Polysciences, Warrington, 
PA). Incubation without primary or secondary antibodies yielded only background levels 
of signal (data not shown).
RNA extraction and cDNA synthesis. Total RNA from cultured DRG neurons was 
extracted using RNeasy mini-columns (Qiagen). The purified RNA was treated with
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RNase-free DNase-1 (Roche) and re-purified using an RNeasy mini-column (Qiagen). 
RNA was then eluted in 50 |jl of water. First-strand cDNA was reverse transcribed in a 
finai volume of 50 pi using 5 p! purified total RNA, 1 mM random hexamer primer 
(Roche), 40 U Superscript II reverse transcriptase (Life Technologies), and 40 U of 
RNase inhibitor (Roche). The buffer consisted of (in mM); 50 Tris-HCI (pH 8.3), 75 KCI, 3 
MgCI2, 10 DTT, and 5 dNTP. The reaction proceeded at 37 °C for 90 min and 42 °C for 
30 min, and was then terminated by heating to 95 °C for 5 min. A parallel reaction with 
identical reagents except for the reverse transcriptase enzyme was performed as a 
negative control to demonstrate the absence of contaminating genomic DMA (data not 
shown).
Quantitative PCR. The relative standard curve method was used to quantify and 
compare RNA extracted from the cultured DRG neurons. An 188 rRNA primer-probe set 
(Applied Biosystems, Foster City, CA) was used as an endogenous control to normalize 
the expression level of the sodium channels. Standard curves for 188 rRNA and each 
sodium channel primer/probe set were constructed using serial dilutions of adult mouse 
DRG cDNA. One cDNA preparation was used to establish the standard curve for all 
experiments. Standards and unknowns were amplified in quadruplets. The standard 
curves for the sodium channel primer/probe sets and endogenous control (rRNA) were 
constructed from their respective mean critical threshold (Cx) values, and the equation 
describing the curve was derived using Sequence Detector software v1.6.3 (Applied 
Biosystems).
Primers and probes for the sodium channel targets were designed using Primer 
Express software (Applied Biosystems) according to the specifications of the TaqMan 
protocol (Winer et al., 1999). Sequences are as follows;
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N avi.9 forward 5’-CACCATCTGCATCATCGTCAAT-3’,
reverse 5’-AGGGTCTAGCGCAATGATCTTG-3’, 
probe FAM-AACTGGGTTTTCACTGGAATTTTCATAGCGG-TAMRA.
Target specificity was confirmed by nucleotide BLAST search. Probes for sodium 
channels were synthesized and purified by Applied Biosystems. Primers for the sodium 
channels and 183 rRNA were used at a final concentration of 900 and 50 nM, 
respectively, whereas the probes were used at a final concentration of 200 nM. The 
primer-probe combinations were not limiting at these concentrations. Amplification was 
done in a 25 pi final volume, under the following cycling conditions: 10 min at 50 °C, and 
then 40 cycles of 95 °C for 15 s followed by 60 °C for 1 min. An AS I Prism 7700 (Applied 
Biosystems) was used to run the PCR reaction and data was recorded using Sequence 
Detector v1.6.3 (Applied Biosystems). Sodium channels and IBS rRNA templates were 
amplified in separate wells.
Data Analysis. A Nikon Eclipse E800 light microscope was used for sample 
observation, and quantitative microdensitometry of fluorescent immunostaining signals 
was obtained using IPLab v3.0 Image Processing software (Scanalytics Inc., Fairfax, 
Virginia). Signal intensities were determined by outlining individual neurons, and IPLab 
integrated densitometry functions were used to calculate mean signal intensities for the 
selected areas. Data from eight side compartments each for the control group and the 
stimulated group were used to obtain data. Experiments were processed in parallel and 
differences were assessed by non-paired f-tests. Neuron counts per area (Fig. 1) were
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quantified by averaging multiple counts (/?=6 per group) of neurons within the side 
compartments of the culture chamber. For the quantitative PCR experiments, differences 
in mRNA expression between the control and stimulated groups were analyzed using 
the non-paired t-test (r? = 4 control, 4 stimulated). All data are presented as mean ± SE.
4.4 RESULTS
Effect o f electrical stimulation on neuron survival. Prior to analyzing the effect of
stimulation on sodium channel expression in cultured DRG neurons, we performed 
several control experiments to distinguish stimulation-dependent changes in channel 
expression from possible effects on cell survival. Morphometric analyses (Fig. 4.1 A) and 
counts of cultured neurons (Fig. 4.IB ) revealed no significant difference in neuron size 
distribution (n=865 neurons) or density (n=511 neurons) after electrical stimulation. The 
majority of neurons in culture were within the 25-40 pm diameter range.
As an additional control, we used immunocytochemistry with subtype-specific 
antibodies and demonstrated the effect of withdrawing NGF from the culture media for 5 
days on the expression of Navi .3, Navi .8 and Navi .9. In cultures deprived of NGF, 
there was a tendency toward an increase in Navi .3 protein, but this did not reach 
statistical significance. In contrast, NGF deprivation resulted in significantly reduced 
levels of Navi .8 and Navi .9 protein compared to cultures containing 50 ng/mL NGF 
(Fig. 4.1C). At the transcript level, withdrawal of NGF induced an 83.3% decrease in 
Navi .8 mRNA and a 57.6% decrease in Navi .9 mRNA as detected by quantitative PCR.
Sodium channel protein is down-regulated by electrical stimulation. Subtype- 
specific antibodies to N av i.3, Navi.8, and N av i.9 were used to determine the quantity 
of sodium channel protein in the cultured DRG neurons after stimulation. Fig. 4.2 shows
49
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
optical intensity quantification of the resuits. Stimulated cultures show a significant 
(p<0.05) down-reguiation of Nav1.8 and Nav1.9 protein compared to non-stimulated 
cultures. Protein expression for Nav1.3 was not statistically different from non-stimulated 
cultures.
Sodium channel mRNA is down-regulated by electrical stimulation. Having 
demonstrated a significant change in Nav1.8 and Nav1.9 protein expression, we further 
examined the expression of these two genes by quantitative PCR analysis of mRNA 
levels. Stimulation caused a significant (p<0.05) down-regulation of Nav1.8 (to 48.9% of 
control level) and Navi .9 (to 63.4% of control level) mRNA (Fig. 4.3).
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Nav1.3 N avl.8 Nav1,9
Fig. 4.1. Electrical stimulation does not influence neuronal survival or size distribution. A. 
Morphological measurements of cultured neurons do not show significant differences 
between any of the experimental conditions. The majority of neurons were within the 25- 
40 pm diameter range. B. Counts of cultured neurons in the stimulated and non- 
stimulated groups showed no significant change in ceil number. C. The effect of NGF 
withdrawal on Nav1.3, Nav1.8, and Nav1.9 protein levels is demonstrated by 
immunocytochemistry. Optical intensity quantification of individual neurons shows a 
significant down-regulation of Nav1.8 and Nav1.9 protein in cultures without NGF (*) 
compared to cultures with NGF (no *). Nav1.3 protein levels were not significantly 
different between +NGF and -NGF cultures. Data are plotted as mean ± SE; * = p<0.05.
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Navi ,3 Nav1. Navi .9
Fig, 4.2. A-F. Representative Images demonstrating fluorescent immunoreactivity for 
Nav1.3, Nav1.8, and N avi.9. Images were converted to grayscale and digitally contrast- 
enhanced using identical parameters to qualitatively illustrate the changes in protein
expression. A. N av i.3, control (non-stimulated); B. N av i.3, stimulated; C. Navl.8
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control; D. Nav1.8, stimulated; E. Nav1.9, control; F. Nav1.9, stimulated; G. Optica! 
intensity quantification from unenhanced images of individual neurons shows a 
significant down-regulation of Nav1.8 and Nav1.9 protein in stimulated cultures (*) 
compared to non-stimulated cultures (no *). Nav1.3 protein levels were not significantly 
different between control and stimulated cultures. Scale bar = 50 pm; data are plotted as 




















Fig. 4.3. Results of quantitative PCR for N av i.8 and N av i.9. Navl.8 and N avi.9 
mRNAs were both down-regulated in stimulated cultures (*) compared to non-stimulated 
cultures. Data are plotted as mean ± SE; * = p<0.05.
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4.5 DISCUSSION
In the present study, we examined the effect of electrica! stimulation on the 
expression of sodium channels N avl3 , N avi.8 and N avi.9 in cultured embryoniG 
mouse DRG neurons. We demonstrated that the expression by DRG neurons of Navl.8 
and N av i.9, but not of Navi.3, is regulated by patterned electrica! stimulation. There are 
several mechanisms that may allow a neuron to adapt to changes in the range of 
afferent or electrical input that it experiences. Calcium-dependent signaling pathways 
involving CaM kinase II and the MAP kinase cascade have been shown to play an 
important role in the regulation of CREB-mediated gene transcription (Buonanno and 
Fields, 1999; Ji and Woolf, 2001; Kornhauser et al., 2002; West et al., 2001; West et al., 
2002), and these pathways can be regulated by neuronal firing (Fields et al., 2001). 
Growth factors, neurotransmitters, and hormones can also exert calcium-independent 
effects on CREB-mediated transcription.
The intracellular level of calcium and its activity-dependent rate of influx can 
influence the expression of TTX-sensitive sodium channels (Brodie et al., 1989). Chronic 
blockade of electrical activity in cultured cardiac myocytes triggers an up-regulation of 
transcription of sodium channel Navi .4 (Offord and Catterall, 1989; Sherman and 
Catterall, 1984). Calcium-mediated down-regulation of sodium channel expression has 
been demonstrated by increasing electrica! stimulation (Chiamvimonvat et al,, 1995). 
Calcium channel activity-dependent regulation of sodium channel expression has also 
been demonstrated in cultured pituitary GH3 cells (Monjaraz et al., 2000). In this study, 
calcium channel agonists (Bay K 8644) led to increased peak sodium currents, while 
antagonists (nimodipine) lowered sodium currents. The regulatory mechanisms linking 
calcium levels to modulation of sodium channel mRNA transcription and expression 
remain unknown.
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Pain following nerve injury is associated with abnormal bursting activity and 
increased sensitivity of DRG neurons whose axons have been transected; alterations in 
VGSC expression are believed to contribute to this phenomenon (Waxman, 1999b; 
Woolf and Salter, 2000). The number and mix of TTX-sensitive and TTX-resistant 
sodium channels in the membrane of a neuron may be a determinant of neuronal 
hyperexcitability; changes in the level of expression of slowly inactivating Navi .8 sodium 
currents can result in altered threshold for action potential generation and an increased 
tendency to fire repetitively (Elliott, 1997; Renganathan et al., 2001; Schild and Kunze,
1997). Moreover, Navi .9 has a strong effect on membrane potential (Cummins et al., 
1999; Herzog et al., 2001) and threshold (Baker et al., 2003) and altered levels of 
Navi.9 should thus have important effects on excitability.
Studies that have examined changes in sodium channel expression following 
inflammation (Djouhri and Lawson, 1999; Tanaka et al., 1998), nerve compression (Dib- 
Hajj et al., 1999b) and transection (Dib-Hajj et al., 1998a; Okuse et al., 1997) have been 
limited by the fact that the mechanism of modulation of expression may involve growth 
factor effects or activity-dependent effects. We have shown here that a change in 
neuronal activity level is sufficient to modulate the expression of two sodium channels. 
Navi .8 and Navi .9. The down-regulation occurred under cell culture conditions in which 
NGF was not a limiting factor (50 ng/ml). Because Navi .3 did not demonstrate an 
activity-dependent change in expression, it is unlikely that stimulation caused a 
generalized down-regulation of all sodium channel gene transcripts. Rather, a selective 
and specific retuning of the electrogenic membrane, which may regulate neuronal gain, 
occurred in response to changes in input.
We suggest that an activity-dependent down-regulation of Navl.8 and N avi.9 
proceeds via a molecular mechanism distinct from the mechanism that mediates growth- 
factor-triggered changes in expression of these channels. If this hypothesis is correct, it
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implies the possibility of new therapeutic approaches that might regulate axonal channel 
expression, and thus excitability, via a previously unstudied activity-dependent pathway.
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CHAPTER 5
DYSREGULATION OF SODIUM CHANNEL EXPRESSION
IN CORTICAL NEURONS IN A RODENT MODEL OF 
ABSENCE EPILEPSY
5.1 SUMMARY
Due to the involvement of cortical neurons in spike-wave discharge (SWD) 
initiation, and the contribution of voltage-gated sodium channels (VGSCs) to neuronal 
firing, we examined alterations in the expression of VGSC mRNA and protein in cortical 
neurons in the WAG/Rij absence epileptic rat. WAG/Rij rats were compared to age- 
matched Wistar control rats at 2, 4, and 6 months. Continuous EEG data was recorded, 
and percent time in SWD was determined. Tissue from different cortical locations from 
WAG/Rij and Wistar rats was analyzed for VGSC mRNA (by quantitative PCR) and 
protein (by immunocytochemistry). SWDs increased with age in WAG/Rij rats. mRNA 
levels for sodium channels Nav1.1 and Nav1.6, but not Nav1.2, were up-regulated in the 
facial somatosensory cortex (at AP+0.0, ML+6.0 mm). This region of cortex 
approximately matches the electrophysiologically determined region of seizure onset. 
Protein levels for Nav1.1 and Nav1.6 were up-regulated in layer ll-IV cortical neurons in 
this region of cortex. No significant changes were seen in adjacent regions or other brain 
areas, including the pre-frontal and occipital cortex. Changes in the expression of 
Nav1.1 and Nav1.6 parallel age-dependent increases in seizure frequency and duration.
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5.2 INTRODUCTION
Neuronal excitability is dependent on the activity of voltage-gated sodium 
channels (VGSCs). Nine VGSC genes are expressed within the nervous system, each 
with different tissue distribution and functional characteristics (Catterall, 2000; Goldin et 
al., 2000). The combination of VGSCs present in a neuronal membrane contributes to its 
electrogenic properties and firing pattern. VGSC expression is a dynamic process, and 
alterations in physiological state as well as injury induce changes in VGSC expression, 
which can alter neuronal behavior (Waxman et al., 2000).
Certain types of epilepsy can result from direct (sodium channel gene mutations) 
or indirect (changes in genes that affect sodium channel expression) pathways (Aronica 
et al., 2001; Bartolomei et al., 1997; Gastaldi et al., 1998; Meisler et al., 2001; Noebeis, 
2002). VGSCs contribute to neuronal bursting (Parri and Crunelli, 1998) and some 
anticonvulsant drugs act via blockade of specific currents produced by sodium channeis 
(Crunelli and Leresche, 2002; Leresche et al., 1998; Spadoni et al., 2002; Taverna et al.,
1998). Alterations in the expression or function of VGSCs that predispose neurons 
toward repetitive firing and network hyperexcitability may be associated with increased 
seizure activity (Scharfman, 2002).
Absence seizures have historically been defined as a generalized non-convulsive 
epilepsy consisting of a sudden arrest of ongoing behavior and impairment of 
consciousness associated with a rhythmic spike-wave discharge (SWD) firing pattern of 
thalamic and cortical neurons. The characteristic biiateraily-synchronous spike-wave 
oscillation, as seen on EEG, results from reverbatory loops of excitation between the 
cortex and thalamus (Avoli and Gloor, 1982; Blumenfeld and McCormick, 2000; 
Destexhe et al., 1999). Ablation studies in rodent and feline models of absence epilepsy 
have demonstrated that an intact cortex and thalamus are necessary for the
58
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
electrophysiological transition to SWD firing (Avoli et al., 1983; Avoli et a!., 1990; 
Danober et al., 1998; Vergnes and Marescaux, 1992).
Although SWD is considered a “generalized” seizure discharge, the anatomical 
region of seizure onset in WAG/Rij (Wistar Albino Glaxo from Rijswijk) rats (a genetic 
model of absence epilepsy (Coenen et a!., 1992)) was recently localized to the facial 
region of the somatosensory cortex, which lies on the lateral cortex near the coronal 
plane of bregma (Meeren et al., 2002). SWDs appear to arise from an increase in burst 
firing in cortical neurons, which causes a large synchronized increase in neuronal firing 
in thalamocortical networks (Bal et al., 2000; Blumenfeld and McCormick, 2000). SWDs 
occur most dramatically in the frontal and parietal neocortical regions and corresponding 
thalamic nuclei with a relative sparing of the limbic and more posterior thalamocortical 
networks (Blumenfeld and McCormick, 2001; Nersesyan et al., 2002; Vergnes et al., 
1990). The underlying molecular and electrophysiological basis of this phenomenon 
remains unidentified.
Because the cortex has been implicated as a focus for initiation of SWD firing, 
and because VGSCs can underlie neuronal bursting, we asked whether there are 
differences in the expression of sodium channel mRNA and protein in the WAG/Rij 
epileptic cortex compared to non-epileptic controls. We attempted to localize the. altered 
sodium channel expression to a specific region of cortex, and furthermore to a specific 
population of neurons within the cortical mantle. This data was correlated to EEG 
recordings in order to establish an age-dependent association between SWD frequency 
and duration and extent of sodium channel dysregulation.
5.3 MATERIALS AND METHODS
Animals. Adult rats of the WAG/Rij (epileptic) strain were compared to age-matched 
Wistar rats (control). The WAG/Rij rat colony at our institution originated from the
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Radiobiological Institute TIMO, in Rijswijk (Reinhold, 1966), and Wistar rats were from 
Charles River Laboratories (Wilmington, MA). WAG/Rij rats exhibit spontaneous 
electrographic seizures characterized by bilaterally synchronous and symmetric SWDs. 
SWDs in these animals occur at a frequency of 7-11 Hz and seizure duration is typically 
2-8 seconds. In this study, animals were individually housed and kept on a 12-hour 
light/dark cycle with unlimited access to food and water, in accordance with NIH 
guidelines for the care and use of laboratory animals; animal protocols were approved 
by the Yale University institutional Animal Care and Use Committee. In total, 25 animals 
were used: 18 (9 epileptic, 9 control) for quantitative PCR analysis and 7 (4 epileptic, 3 
control) for immunocytochemistry. Animals were grouped by age: 2 month (2 epileptic, 2 
control), 4 month (3 epileptic, 3 control), and 6 month (4 epileptic, 4 control) rats were 
used for the PCR experiments, and 4 month rats were used for immunocytochemistry. 
All animals had electrodes implanted for electrophysiological recording.
EEG recordings and analysis. For EEG recordings, tripolar electrodes (Plastics One 
Inc., Roanoke, VA) were fixed to the skull. Animals were deeply anesthetized 
intramuscularly with ketamine (100 mg/kg), xylazine (5.2 mg/kg), and acepromazine (1.0 
mg/kg) and placed in a stereotactic frame (David Kopf Instruments, Tujunga, CA). Level 
of anesthesia was monitored by respiration, heart rate, glabrous skin perfusion, and 
response to foot pinch. Small burr holes were made in the skull without disturbing the 
dura and electrodes were secured to the skull using 1.60 mm stainless steel screws 
(Plastics One). EEG recording electrodes were placed at AP +2.0, ML +2.0 mm, and AP 
-6.0, ML +2.0 mm and a ground electrode was placed in the midline over the cerebellum. 
Dental acrylic (Lang Dental Mfg. Co., Wheeling, IL) was used to fix the electrode unit in 
place. Following a one-week recovery period, continuous EEG data was recorded from 
awake-behaving rats for two hours per day (between 10:00am and 4:00pm) over a
60
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
three-day period for each animal. EEG signals were amplified with a Grass CP 511 unit 
(Grass-Telefactor, Astro Med, Inc., West Warwick, Rl), with band pass filter settings of 1 
Hz to 100 Hz. Signals were digitized with a CED Power 1401, and stored and analyzed 
using Spike 2 software (Cambridge Electronic Design, Cambridge, UK). SWDs were 
defined as large-amplitude (>400 pV peak-to-peak) rhythmic 7-11 Hz discharges with 
typical spike-wave morphology lasting >0.5 s. Start and end times for all SWDs were 
marked, and percent time in SWD firing pattern was then calculated as (sum of SWD 
interval durations / total recording time) x 100%, for all WAG/Rij (epileptic) and Wistar 
(control) rats.
RNA extraction and cDNA synthesis. Rats were deeply anaesthetized with CO2 , 
decapitated, and brains were quickly removed. Twelve plugs of tissue, each measuring 
approximately 1 mm^ were dissected from the left and right cortex of each rat using 
iridectomy scissors. For each hemisphere, three plugs at AP +3,0,-6 and ML +6 mm, 
and three plugs at AP +3,0,-6 and ML +2 mm were taken (see Fig. 2). Tissue plugs 
included all six layers of cortex but did not extend into subcortical tissue. Tissue was 
immediately frozen in dry ice and stored at -80  °C until use.
Total RNA from brain tissue was extracted using RNeasy mini columns (Qiagen). 
The purified RNA was treated with RNase-free DNase-1 (Roche) and re-purified using an 
RNeasy mini-column (Qiagen). RNA was then eluted in 50 pi of water. First-strand cDNA 
was reverse transcribed in a final volume of 50 pi using 5 pi purified total RNA, 1 mM 
random hexamer primer (Roche), 40 U Superscript II reverse transcriptase (Life 
Technologies), and 40 U of RNase inhibitor (Roche). The buffer consisted of (in mM): 50 
Tris-HCI (pH 8.3), 75 KCI, 3 MgCI2, 10 DTT, and 5 dNTP. The reaction proceeded at 37 
°C for 90 min and 42 °C for 30 min, and was then terminated by heating to 95 °C for 5 
min. A parallel reaction was performed as a negative control to demonstrate the absence
61
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
of contaminating genomic DNA (data not shown) by using all identica! reagents except 
for the reverse transcriptase enzyme.
Quantitative real-time PCR. The relative standard curve method was used to quantify 
and compare RNA extracted from different regions of cortex in epileptic (WAG/Rij) and 
control (Wistar) rats. An 18S rRNA primer-probe set (Applied Biosystems) was used as 
an endogenous control to normalize the expression level of the sodium channels. 
Standard curves for 188 rRNA and each sodium channel primer/probe set were 
constructed using serial dilutions of control brain cDNA. Standards and unknowns were 
amplified in quadruplets. Standard curves for the sodium channel primer/probe sets and 
endogenous control (rRNA) were constructed from respective mean critical threshold 
(C t )  values; the equation describing the curve was derived using Sequence Detector 
software v1.6.3 (Applied Biosystems).
Primers and probes for the sodium channel targets were designed using Primer 
Express software (Applied Biosystems) according to the specifications of the TaqMan 
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Target specificity was confirmed by nucleotide BLAST search. Primers and probes for 
sodium channels were synthesized and purified by Applied Biosystems. Primers for the 
sodium channels and 18S rRNA were used at a final concentration of 900 and 50 nM, 
respectively, whereas the probes were used at a final concentration of 200 nM. The 
primer-probe combinations were not limiting at these concentrations. Amplification was 
done in a 25 pi final volume, under the following cycling conditions: 10 min at 50 °C and 
then 40 cycles of 95 °C, 15 sec, followed by 60 °C, 1 min. An AS I Prism 7700 (Applied 
Biosystems) was used to run the PCR reaction and data was recorded using Sequence 
Detector v1.6.3. Sodium channels and 18S rRNA templates were amplified in separate 
wells. The amount of mRNA in different regions of cortex was reported as the ratio of 
mRNA in the epileptic rats divided by mRNA in the control rats.
Immunocytochemistry. Rats were anesthetized with ketamine/xylazine (80/5 mg/kg
i.p.) and then underwent intracardiac perfusion with 0.01 M PBS followed by a 4% 
solution of cold buffered paraformaldehyde. Brains from 4 month WAG/Rij and Wistar 
rats were postfixed and cryoprotected in 30% sucrose in 1 M phosphate buffer solution 
(PBS), and coronal sections (10 pm) of the cerebral hemispheres, including all regions 
studied by quantitative PCR, were cut. Slices were mounted onto slides and incubated in 
blocking solution (5% normal goat serum and 1% BSA in PBS) containing 0.1% Triton X- 
100 and 0.02% sodium azide at room temperature for 30 min., then incubated with 
subtype-specific antibodies to Na'*' channel a-subunits Navl.1 (residues 465-481, 1:100 
dilution, Alomone, Jerusalem), Navi .2 (residues 467-485, 1:100 dilution, Alomone), 
Navi .6 (residues 1042-1061, 1:100, Alomone), and a phospho-CREB antibody (1:50, 
Cell Signaling Technology, Inc., Beverly, MA) overnight at 4 °C. Sections were washed
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in PBS and incubated with biotinylated goat anti-rabbit serum (1:1000, Sigma) in 
blocking solution for 3 hours, then washed in PBS and incubated in avidin-HRP (1:1000, 
Sigma) in blocking solution for 3 hours. Sections were washed in PBS and exposed to 
heavy metal enhanced 3,3’-diaminobenzidine^4HCi in IX  peroxide substrate buffer 
(Pierce, Rockford, Illinois) for 7 min.
Data Analysis. A Nikon Eclipse E800 light microscope was used for sample 
observation, and quantitative microdensitometry of immunostaining signals was obtained 
using IPLab vS.O Image Processing software (Scanalytics Inc., Fairfax, VA). Signal 
intensities were determined by outlining individual cortical neurons, and IPLab integrated 
densitometry functions were used to calculate mean signal intensities for the selected 
areas. Results from identical regions and layers of cortex in WAG/Rij (epileptic) rats 
were compared to Wistar (control) rats processed in parallel and differences were 
assessed by non-paired f-tests. Immunopositivity was quantified by averaging multiple 
counts within a defined area (1.9x10Vm^) within layers II-IV. For counts of 
immunopositive neurons, cells that displayed a signal of >50% above background were 
scored as positive.
For the EEG data in Fig. IF  and the quantitative PCR data in Fig. 2, differences 
were analyzed using AN OVA with post-hoc Fisher’s least significant difference analysis 
with Bonferroni adjustment. An alpha level of 0.05 was used as a threshold for statistical 
significance.
5.4 RESULTS
Seizure frequency and duration Increase w ith age in the WAG/Rij model of 
absence epilepsy. SWDs begin to be seen at approximately 3 months of age in 
WAG/Rij rats (Coenen and Van Luijtelaar, 1987; Coenen et al., 1992). in the animals we
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studied, EEG recordings from WAG/Rij rats showed an age-related increase in the 
number of seizures per unit time, and in the mean duration of each seizure. Age- 
matched control Wistar rats did not show SWD activity (Fig. 5.1 A). Examples of typical 
recordings from WAG/Rij rats at different ages are shown in Fig. 5.1B-D. SWDs, 
consisting of high voltage 7-11 Hz rhythmic spike-wave activity, are shown on an 
expanded timescale in Fig. 5.1 E. To correlate the molecular changes with SWD activity 
at different ages, we calculated the percentage of time in SWD (Fig. 5.1 F). Percent time 
in SWD depends on both the number of SWDs per minute and the duration of each 
SWD. Mean seizure durations were 2.8 ± 1.17 s (mean ± SD) at 2 months, 2.6 ± 1.67 s 
at 4 months, and 3.1 ± 1.83 s at 6 months. Mean SWDs per minute were 0.02 ± 0.017 at 
2 months, 0.19 ± 0.080 at 4 months, and 0.14 ± 0.061 at 6 months. Percent time in SWD 
was 0.11± 0.070 (mean ± SE) at 2 months, 0.51±0.141 at 4 months, and 0.74±0.188 at 6 
months (n=23 animals). The difference between 2 month and 4 month, and 2 month and 
6 month percent time in SWD was statistically significant. (*=p<0.05, Fig. 5.1 F). Although 
the 6 month WAG/Rij rats had a greater percent time in SWD compared to 4 months, the 
difference did not reach statistical significance.
Nav1.1 and Nav1.6 mRNAs are up-regulated in epileptic cortex. Sodium channels 
N a v l.i, N av i.2, and N av i.6 were found to be expressed in the cortices of both control 
and epileptic animals. N avi.3 was expressed at very low levels in both control and 
epileptic animals, and Navi .8, which has been shown to be expressed in CNS tissue in 
some pathologic conditions (Black et al., 2000) was not detected. Tissue plugs were 
taken from 6 month old WAG/Rij (epileptic) and age-matched Wistar (control) rat cortex. 
Quantitative PCR experiments showed a significant up-regulation of Navi.1 and N avi.6 
mRNA selectively at ML+6 mm in the transverse plane at bregma (n=8 animals, 
*=p<0.05. Fig. 5.2). This region of cortex approximately matches the
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electrophysioiogically determined region of seizure onset, as reported by Meeren et a!., 
within the peri-oral area of the somatosensory cortex (Meeren et a!., 2002). PCR results 
for primer/probe sets yielded statistically insignificant differences between matched left 
and right hemispheric tissue sections; therefore data from bilaterally equivalent tissue 
sections were combined. Nav1.2 did not show a significant change between WAG/Rij 
and Wistar rats in any region of cortex tested (Fig. 5.2).
N avl.i and Nav1.6 proteins are up-regulated in layer II-IV cortical neurons. Having 
demonstrated a region-specific up-regulation of Navl.1 and Nav1.6 mRNA, we next 
asked whether these changes occurred within a specific population of neurons within the 
cortex. Immunocytochemical experiments using subtype-specific antibodies for Nav1.1 
and Nav1.6 on 4 month WAG/Rij and Wistar rats showed up-regulation of these 
channels in layer II-IV cortical neurons of WAG/Rij rats. Layer II-IV neurons were 
identified by their neuronal morphological characteristics and by their proximity to the 
pial surface superficially. Fig. 5.3A-C shows coronal sections of cortex at bregma and +6 
in the transverse plane, demonstrating the significant change in sodium channel 
expression (for Navl.1 and N avi.6, but not N av i.2) in layers II-IV in epileptic rats. Fig. 
5.3D shows cortical staining with phospho-CREB antibody, a marker of transcription 
activation. The up-regulation of sodium channels N av l.i and N av i.6 is paralleled by an 
increase in neuronal phospho-CREB immunoreactivity in epileptic cortex layers II-IV 
(Fig. 5.3D). Fig. 5.3E,F represent a quantification of the sodium channel data (n=4 
epileptic, 3 control, and 668 total neurons, *=p<0.05). Immunocytochemical experiments 
done in the absence of primary antibody yielded only non-specific background levels of 
signal (data not shown). Sodium channel protein expression and pGREB expression in 
adjacent regions and in other areas of cortex and thalamus did not show a significant 
difference between epileptic and non-epileptic animals (data not shown).
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Age-dependent dysregufation o f sodium channel expression In WAG/Rij rats. To 
further assess the connection between altered sodium channel expression and seizure 
activity, we examined age-dependent changes in sodium channel mRNA expression. 
Fig. 5.4 shows the variation in Nav1.1, Nav1.2, and Nav1.6 mRNA levels at AP+0.0, 
ML+6.0 mm (anatomical location E on Fig. 5.2) with respect to age in the WAG/Rij model 
compared to Wistar animals. Navl.1 and N av i.6 mRNA levels increase progressively 
over the three time points studied in the WAG/Rij rats.
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Fig. 5.1. Spike-wave discharges increase with age in WAG/Rij rats. A, Typical recording 
from a Wistar control rat at 7 months of age showing normal EEG activity with no SWDs. 
B-D, Typical examples of EEG recordings from WAG/Rij rats showing SWDs of 
increasing duration and frequency of occurrence with age (8 = 2 month WAG/Rij, C = 4 
month WAG/Rij, D = 6 month WAG/Rij). Section expanded in E is indicated by horizontal 
bars. E, Segment of data from D shown at expanded time scale to demonstrate typical 
morphology of SWDs. F, Control Wistar rats aged 2-6 months exhibited no SWDs 
(n=10). Percent time spent in SWD firing pattern is shown for WAG/Rij rats at 2 months 
(n=2), 4 months (n=6), and 6 months (n=5). Each rat was recorded for sessions lasting 2 
hours each on 3 consecutive days (6 hours total) just before performing the molecular 
studies. Data is plotted as mean ± SE, * = p<0.05 (4 and 6 month each compared to 2 
month, AN OVA with post-hoc Fisher’s least significant difference analysis with 
Bonferroni adjustment).
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1.
f
Fig. 5.2. Sodium channel mRNA In WAG/Rij and Wistar cortex. Anatomical locations of 
tissue plugs used for quantitative PCR analysis are indicated on inset drawing of rat 
brain. The histogram shows the ratio of sodium channel mRNA levels in the neocortex of 
6 month old WAG/Rij (epileptic) rats compared to age-matched Wistar (control) rats. At 
anatomical location “E”, there is a statistically significant increase in Nav1.1 (□ ) and 
Nav1.6 mRNA (■), but not Nav1,2 mRNA (H), in the epileptic animals compared to 
control animals. Data is plotted as mean ± SE; n = 8 animals, * = p<0.05, ANOVA with 
post-hoc Fisher’s least significant difference analysis with Bonferroni adjustment.
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Fig. 5.3. Sodium channel protein in layers II-IV neurons of WAG/Rij and Wistar rat 
cortex. A-D, Coronal sections of cortex at bregma and +6 in the transverse plane 
(location E in Fig. 2) showing layers of cortical mantle. Immunostaining in control rats (no 
*) versus WAG/Rij rats (*) for Nav1.1 (A), Navi .2 (B), Navi .6 (0), and phopho-GREB (D) 
antibodies are shown. Pial surface is at the top of image, wm = white matter, scale bar = 
100pm. The control and epileptic images were digitally contrast-enhanced using identical 
parameters to qualitatively illustrate the up-regulation of transcripts. E, Optical intensity 
quantification from unenhanced images of individual neurons in layers II-IV shows 
increased staining with N av l.i and Navi.6 antibodies in the epileptic animals (■ ) 
compared to controls (□ ), indicating up-regulated sodium channel protein. Layer V-V! 
pyramidal neurons and neurons in other regions of cortex did not show a significant
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change in sodium channel expression between epileptic and control animals (data not 
shown). F, Quantification of immunopositive neurons for each sodium channel antibody 
in layers II-IV. Epileptic animals (■ ) showed increased numbers of Nav1.1 and Nav1.6 
immunopositive neurons compared to control animals (□). Data is plotted as mean ± 









Fig. 5.4. Dysregulated sodium channel expression in layer II-IV cortical neurons parallels 
age-dependent increase in seizure frequency in WAG/Rij rats. The ratio of expression of 
sodium channel mRNA levels between epileptic and control rats for Nav1.1 (□ )  and 
Nav1.6 (■ ) mRNA, but not Nav1.2 mRNA (H), increases from 2 months to 6 months. 
Data is plotted as mean ± SE.
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5.5. DISCUSSION
This study demonstrates for the first time that there is dysregulated expression of 
voltage-gated sodium channels in cortical neurons in a rodent model of absence 
epilepsy. We focused on the cortex due to the possible role of the facial somatosensory 
cortex In initiating seizures, based on previous studies (Meeren et a!., 2002). We used 
quantitative PCR to identify a specific region of cortex where sodium channel mRNA 
expression was different in epileptic (WAG/Rij) and non-epileptic (Wistar) rats. We then 
used immunocytochemistry to localize the change in sodium channel expression to a 
specific population of neurons in the cortex. Our data show that mRNA levels for sodium 
channel genes Nav1.1 and Navi .6 are increased in the lateral aspect of the cortex in the 
plane of bregma and that layer II-IV cortical neurons in this region contain elevated 
N av l.i and N av i.6, but not N av i.2, protein. Interestingly, this region of cortex 
corresponds anatomically to the electrophysiologically-determined region of seizure 
onset, as reported by Meeren et al., within the facial region of the somatosensory cortex 
(Meeren et al., 2002). Increased phospho-CREB immunoreactivity in these cortical 
neurons reflects increased transcription activation and neuronal activity (Buonanno and 
Fields, 1999) in the epileptic vs. control animals, which may be associated with the 
observed changes in N avl.i and N avi.6 expression. Although we did not detect 
qualitative changes in sodium channel expression in subcortical regions such as the 
thalamus or cerebellum, future quantitative studies of sodium channel expression in 
subcortical structures will be necessary to determine whether or not changes occur there 
as well.
Layer II-IV neurons, and the intracortical currents they produce, are a major 
factor in the generation of SWDs (Kandel and Buzsaki, 1997). Since the rhythmic 
oscillations of SWDs depend on cortico-thalamic circuits arising in deeper layers of 
cortex (layers V-VI), it is interesting that the initiation of this pathological firing pattern
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correlates to abnormal sodium channel expression in other more superficial layers 
(layers II-IV) of cortex.
Navl.1 and N avi.6, in particular, are thought to be capable of producing a 
persistent current (Maurice et a!., 2001; Raman et al., 1997; Smith et a!., 1998) 
associated with neuronal bursting and hyperexcitability (Parri and Crunelli, 1998; Tanaka 
et al., 1999). This current could generate bursting In neurons, which could potentially 
contribute to an epileptic phenotype. The anti-convulsant drugs valproate and 
lamotrigine reduce the persistent current in cortical neurons (Spadoni et al., 2002; 
Taverna et al., 1998) and ethosuximide reduces persistent sodium current in thalamic 
and cortical neurons (Crunelli and Leresche, 2002; Leresche et al., 1998). In addition, 
Navi .6 sodium channels populate the neuronal axon hillock and therefore increased 
channel density at this site could lower the threshold for action potential generation 
(Jenkins and Bennett, 2001). The developmental and regulatory processes that control 
the transcription, cellular expression, and plasticity of sodium channel genes in the 
cortex are unknown, and therefore we cannot conclude whether the changes observed 
here are a cause or result of the increased neuronal activity.
Burst firing appears to be essential for the generation of SWDs (Bal et al., 2000; 
Blumenfeld and McCormick, 2000). Dysregulated expression of VGSCs can play a 
crucial role in enhanced burst firing of cortical and other neurons (Brumberg et al., 2000; 
Waxman, 2001). In fact, it has been proposed that enhanced burst firing resulting from 
VGSC-mediated action potentials may constitute a final pathway of electrical 
hyperexcitability in interictal and ictal activities in epilepsy (Bartolomei et a!., 1997; Titan 
et al., 1995).
At the genetic and molecular level, most forms of epilepsy result from neuronal 
migrational abnormalities, metabolic defects, or accumulation of inappropriate material 
that alters neuronal function (Segal, 2002). The WAG/Rij model of absence epilepsy has
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an undetermined genetic basis (Coenen et al., 1992; Peelers et a!., 1992). Currently, no 
single sodium channel mutation has been linked or attributed to this model. Because we 
have demonstrated a change in the expression of two sodium channel genes, it is 
possible that the molecular defect in WAG/Rij rats occurs upstream of single gene 
transcription. Altered availability of neurotrophic transcription factors, which can regulate 
the developmental expression of multiple genes and gene families, may be responsible 
for the dysregulation of sodium channel expression in this model (Noebels, 2002),
Absence seizures have traditionally been classified as a type of generalized 
epilepsy (ILAE Classification, 1981). There may, however, be crucial nodes within the 
brain that are most important for generating these seizures (Blumenfeld, 2003; 
Blumenfeld et al., 2003). The focal dysregulated expression of Navl.1 and N avi.6 
reported here Is associated with an age-dependent increase in seizures and roughly 
corresponds to the electrophysiologically-determlned region of seizure onset (Meeren et 
al., 2002). Therefore, although absence seizures cause an impairment of consciousness 
and involve widespread brain regions, they may in fact initiate as focal 
electrophysiological events which secondarily generalize. Improved detection methods 
and more time-sensitive physiological measurements will continue to Improve our 
understanding of this process.
In the WAG/Rij model, we report that an age-related Increase in percent time in 
SWD firing (Fig. 5.1) is associated with a progressive increase in expression of Navl.1 
and Navi.6 transcripts in layer II-IV cortical neurons in specific regions of cortex (Fig.
5.4). The critical question of whether the changes in sodium channel expression that we 
observed are a cause or effect of increasing seizure activity remains unanswered by this 
study. Future experiments examining the effect of either subtype-specific sodium 
channel blockers, or targeted knock-down of specific sodium channel transcripts, on 
SWD firing, will be necessary In order to discern whether the changes in expression of
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Nav1.1 and Nav1.6 are a primary or secondary effect, and whether these changes have 
any functional significance.
Understanding the molecular basis for changes in neuronal activity during spike- 
wave seizures may help direct the development of new treatments for this disorder. Our 
results raise the possibility that altered expression of Nav1.1 and Navi .6 in cortical 
neurons may play a role in either the generation of, or response to, SWD firing seen in 
absence epilepsy. If the molecular mechanisms of enhanced burst firing can be 
correlated to specific regional alterations in sodium channel expression in human 
epilepsy, gene therapy and other molecular approaches to treating severe generalized 
seizure disorders may be possible.
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CHAPTER 6
CONCLUSIONS
6.1 ACTIVITY-DEPENDENT MODULATION OF VGSC EXPRESSION
The preceding chapters present evidence that changes in neuronal activity 
modulate the expression of VGSCs, which in turn regulate neuronal excitability and 
responsiveness. This effect was demonstrated within several populations of neurons, in 
both physiological and pathological conditions. As discussed below, the consequences 
of these changes are complex; some appear to be adaptive and beneficial, while others 
may over time contribute to neuronal overactivation and injury, and even drive end-organ 
damage.
6.2 MOLECULAR CHANGES WITHIN NEURONS IN THE DIABETIC BRAIN
Type I and type II diabetes both result in downstream complications, including 
renal dysfunction, coronary artery disease, retinopathy, peripheral neuropathy, and 
stroke, which can compromise quality of life or even be life-threatening (Donnelly et al., 
2000). Chronic hyperglycemia, which results from decreased production of insulin in type 
I diabetes, and increased peripheral resistance to insulin in type II diabetes, disrupts 
cellular homeostasis and normal physiology. At least four metabolic pathways involving 
the shunting of excess glucose are known to participate in the generation of 
hyperglycemic end-organ damage (Brownlee, 2001); 1) The polyol pathway is activated 
during hyperglycemia, and leads to consumption of NADPH and depletion of GSM,
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which lower the threshold for intracellular oxidative injury. 2) Increased formation of 
advanced glycosylation end-products (AGEs) damages endothelial cells, thus 
contributing to vascular damage. 3) Diacylglycerol (DAG) activation of protein kinase C 
(PKC) occurs during hyperglycemia and has adverse effects on blood flow and vascular 
permeability. 4) increased shunting of glucose into the hexosamine pathway leads to 
increased proteoglycan and 0-linked glycoprotein synthesis. Over time, the metabolism 
of excess glucose through these alternative metabolic pathways contributes to vascular 
and end-organ injury (Donnelly et al., 2000). Metabolic activity within these pathways 
does not depend on neuronal activity and thus in the aggregate these pathways 
constitute a neurologically "passive” response to hyperglycemia (Fig. 6.1, left).
While the direct effects of glucose overload and pathogenesis involving these 
passive metabolic pathways account for much of the pathology associated with diabetes, 
the results presented in Chapters 2 and 3 suggest that a second neurologically “active” 
pathway, driven by neuronal activity, may contribute to end-organ pathology.
The diabetic state induces alterations in gene transcription within neurons of the 
CNS. Although some of the changes (e.g. up-regulated vasopressin production in the 
diabetic supraoptic nucleus (SON); see Chapter 2) result in altered neuronal function 
which is beneficial in the acute setting, there is evidence that over time, prolonged 
changes in neuronal gene transcription within the diabetic brain may be maladaptive, 
and underlie an “active” response that can drive pathogenesis and end-organ damage 
(Fig. 6.1, right).
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Fig. 6.1. Chronic hyperglycemia induces both neurologically “active” (right) and 
neurologically “passive” (left) cellular responses.
An increase in serum glucose raises serum osmolality at the rate of 1 mOsm/L 
per 18 mg/dL glucose. Hyperosmolality triggers both behavioral (polydipsia) and 
physiological (natriuresis, water retention) responses within the body, which aim to 
maintain solute balance and minimize fluid shifts between intracellular and extracellular 
environments. This adaptive response to hyperosmolality is mediated by MNCs within 
the hypothalamic supraoptic (SON) and paraventricular (PVN) nuclei, which increase 
their production and secretion of vasopressin when plasma osmolality rises (see Fig.
2.5) (Dheen et al., 1994b; Serino et al., 1998). MNCs are osmosensitive neurons which 
contain mechanosensitive stretch-inactivated cation channels capable of detecting 
changes in extracellular osmolality (Chakfe and Bourque, 2000; Voisin and Bourque, 
2002). These changes in osmolality are encoded by MNCs as series of action potentials,
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which propagate to the MNC terminals within the neuropituitary and regulate the amount 
of vasopressin released. Action potentials in the MNCs are produced in a characteristic 
bursting pattern (Andrew and Dudek, 1983), and are generated by the opening of 
voitage-gated sodium channels (VGSCs). The contribution of sodium channel activation 
to vasopressin release has been demonstrated by showing that application of the 
sodium channel blocker tetrodotoxin (TJX) to dissociated MNCs strongly reduces 
vasopressin secretion (Sperlagh et al., 1999).
The hyperosmolar state is associated with a chronically elevated demand for 
vasopressin. MNCs adapt to this demand by altering the rate of transcription of the gene 
for vasopressin (Luo et al., 2002). However, the transition from a quiescent to a bursting 
state when MNCs are confronted with an increase in osmotic pressure is not just a 
change in vasopressin synthesis and release -  it is accompanied by an up-regulation of 
activity of VGSC genes and insertion of additional sodium channels in the membranes of 
the MNCs, a change which lowers the threshold for generation of action potentials. 
Sodium channel a-subunits N avi.2 and N avi.6 are the predominant sodium channel 
subtypes expressed in MNCs (Tanaka et al., 1999). When MNCs in healthy rats are 
exposed to oral salt-loading, transcription of the Navi .2 and Navi .6 genes is up- 
regulated and new Navi .2 and Navi .6 channels are produced and inserted into the 
MNC plasma membrane. Increased densities of sodium channels lower the neuronal 
threshold for firing and poise neurons, including the MNCs (Klein et al., 2002), to fire 
spontaneously and in bursts (Criil, 1996; Parri and Crunelli, 1998; Taddese and Bean, 
2002). The elevated levels of functional sodium channels in the diabetic MNCs also 
enable greater membrane depolarizations in response to stimulation. As a result, there is 
greater calcium entry into the neuron which may facilitate vasopressin vesicle fusion and 
secretion of vasopressin (Scroggs and Fox, 1992). Thus there is a molecular remodeling
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of the MNCs that supports the release of vasopressin under hyperosmolar conditions 
(Tanaka et a!., 1999).
The hyperosmolality associated with diabetes has been shown to induce similar 
changes in MNCs, which have been studied in the STZ-induced diabetic rat model. 
Expression of the gene for vasopressin is strongly up-regulated within MNCs in diabetes. 
The transcription of mRNA and synthesis of protein for the Navi .2 and Navi .6 sodium 
channels are also up-regulated in response to the increased osmolality that 
accompanies hyperglycemia (Figs. 2.2, 2.3) (Klein et al., 2002). Electrophysiological 
analysis of acutely dissociated MNCs from diabetic animals shows increases in the 
densities of two distinct sodium currents (transient and persistent), indicating that 
functional VGSCs have been inserted into the cell membranes of the MNCs (Fig. 2.4) 
(Klein et al., 2002). Thus, similar to the hyperosmolar state in the absence of diabetes, 
there is a molecular remodeling of MNCs in untreated diabetes.
The up-regulated expression of VGSCs suggests that the activity level of MNCs 
should be chronically increased in untreated diabetes. Several studies have examined 
the expression of markers of neuronal activity within the SON in STZ-induced diabetes 
and the results support this hypothesis. Expression of c-fos protein (Fos), a marker for 
neurons with high states of activity, is up-regulated in the SON and PVN after four weeks 
of STZ-induced diabetes (Zheng et al., 2002). Likewise, neuronal nitric oxide synthase 
(NOS) mRNA levels are markedly up-regulated in SON and PVN neurons in STZ- 
induced diabetic rats (Luo et al., 2002; Serino et al., 1998). This increase in NOS 
expression can be reversed with normalization of glucose by either insulin treatment or 
dietary restriction (Serino et a!., 1998). Because neuronal NOS is activated by calcium 
influx through NMDA receptors, the expression of the NMDA receptor NMDAR1 has 
been assessed in STZ-induced diabetes and was found to be up-regulated in SON and 
PVN neurons (Luo et al., 2002). In the same study expression of the glutamate receptor
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GluR2/3 subunit, which endows NMDA receptors with calcium selectivity and limits 
calcium influx, was found to be down-regulated within the diabetic SON, which might 
allow further intracellular calcium accumulation (Luo et al., 2002). These findings provide 
additional support for the idea that in diabetes, increased demand for vasopressin leads 
to an ensemble of molecular changes which contribute to a high level of activity within 
vasopressin-producing neurons.
Although short-term rises in vasopressin synthesis and release by MNCs serve 
an important homeostatic role, sustained elevations in vasopressin levels have been 
implicated in the development of renal failure (Ahloulay et al., 1999; Bouby et al., 1999; 
Donnelly et al., 2000), and there is evidence for degeneration of MNCs in the SON which 
have been driven into a chronically active state in diabetes. The link between high levels 
of MNC activity and vasopressin release, and renal injury, appears to involve V2 
vasopressin receptors, located in the basolateral membrane of principal cells in the renal 
medullary collecting duct and cortical arcade (Laycock and Hanoune, 1998), which 
mediate the antidiuretic effect of vasopressin. Activation of the V2 receptor through a G- 
protein-linked signaling cascade ultimately leads to the expression and insertion of the 
water channel aquaporin 2 into the apical membrane surface. By introducing water- 
permeable channels into the renal collecting duct, vasopressin acutely prevents (or 
limits) a rise in serum osmolality (Bankir et al., 2001). However, long-term overactivation 
of V2 receptors by chronically elevated serum vasopressin leads to glomerular 
hyperfiltration, albuminuria, and renal hypertrophy (Bardoux et al., 1999). These 
structural and physiological changes, which result from chronically increased 
vasopressin levels, are characteristic of diabetic nephropathy and can progress to renal 
failure (Fig. 2.5) (Ahloulay et al., 1999; Bouby et al., 1999; Donnelly et al., 2000), 
Normalization of vasopressin levels prevents the development of these changes and, in
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vasopressin-deficient STZ-induced diabetic animals, these changes are not observed 
(Bardoux et al., 1999).
In addition to contributing to end-organ damage, the changes within 
hypothalamic neurons may over time contribute to their loss. While short-term changes 
in MNC activity may be adaptive, more chronic changes, which are associated with 
prolonged alterations in gene transcription, have been found to be associated with 
several structural alterations, suggesting that there is degeneration of hypothalamic 
neurons in the chronically diabetic SON and PVN. These changes were presented in 
Chapter 3. Other studies have confirmed these findings. Using Cresyl Violet (NissI) 
staining, some neurons within the diabetic SON appear hypertrophic and vacuolated, 
while others are shrunken and hyperchromatic (Luo et al., 2002). These changes 
become more pronounced with length of time of STZ-induced diabetes. Vasopressin 
immunoreactivity, while still above control levels, falls off in long term (>2 months) 
diabetic animals (Luo et al., 2002), providing additional indirect evidence that there may 
be neuronal damage and functional insufficiency due to chronic overactivation in 
diabetes. Ultrastructural studies of SON and PVN neurons in prolonged diabetes have 
demonstrated abnormal axonal profiles, abnormal dendritic morphology, and abnormal 
somata; after six months of STZ-induced diabetes, substantial neuronal degeneration is 
present within the SON and PVN (Dheen et al., 1994a).
The molecular changes within hypothalamic MNCs, described above, appear to 
contribute to the degeneration of these neurons. As discussed above, activation of 
MNCs triggers an up-regulation of NOS and NMDAR (Luo et al., 2002). Chronic 
overstimulation of NMDAR can lead to an accumulation of intracellular calcium, which in 
turn drives the production of NO (Coyle and Puttfarcken, 1993; Dawson et al., 1991). 
While elevated levels of NO may be protective against damage caused by the 
accumulation of reactive oxygen species (part of the “passive” response, see Fig. 6.1)
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(Brownlee, 2001), high levels of NO can also mediate glutamate toxicity secondary to 
neuronal overactivation. Chronic diabetes thus may, via the sustained hyperactivity that 
it produces, trigger the death of vasopressin-producing neurons.
Chronic hyperglycemia therefore triggers changes in the rate of transcription of 
specific genes within neurons of the hypothalamus and hippocampus, and possibly in 
other brain regions. It appears that over time these modifications of gene transcription 
evoke changes in neurons, which contribute to the development of secondary 
complications of diabetes.
While dietary and medical management of hyperglycemia are often sufficient to 
delay or prevent the appearance of secondary complications, the changes in neuronal 
gene transcription discussed in this review may also represent an opportunity for 
therapeutic intervention. In the hypothalamus, normalization of sodium channel 
expression or block of abnormal sodium channel activity (Klein et al., 2002; Sperlagh et 
al., 1999) in MNCs would be expected to decrease vasopressin secretion, and might 
therefore attenuate the hyperfiltration, albuminuria, and renal hypertrophy associated 
with increased vasopressin release, thus slowing the onset of diabetic nephropathy 
(Bardoux et al., 1999).
As the changes in neurons that occur in diabetes become better understood, it 
appears that the pathogenesis of end-organ damage in diabetes involves two distinct 
mechanisms: 1) neurologically “passive” shunting of excess glucose through alternative 
cellular metabolic pathways, which causes diffuse vascular injury and oxidative damage; 
and 2) “active” modulation of neuronal gene transcription in response to hyperglycemia, 
which alters neuronal structure and function, and in turn, can lead to physiological 
deficits (Fig. 6.1). Recognition of the active neuronal pathway may open up new 
therapeutic approaches, distinct from the classical therapies that work on the passive 
metabolic pathways, that can slow or prevent end-organ damage in diabetes.
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6.3 STIMULATION-DEPENDENT PLASTICITY OF VGSC EXPRESSION
The results described in Chapter 4 provide evidence that the expression of 
specific sodium channel genes can be modulated by changes in neuronal activity level. 
Following stimulation consisting of 10 Hz pulses lasting 0.5 s every 2 seconds, 12 hours 
per day, for 5 days, expression of N avi.8 and N avi.9 mRNA and protein was down- 
regulated, while Navi .3 was unchanged (Klein et al., 2003a). The differential regulation 
of transcription of sodium channel subtypes suggests that the activity-dependent 
modulation of transcription is gene specific, and not the result of a generalized up- or 
down-regulation of neuronal biosynthetic activity. These results are in concordance with 
studies examining the effect of a sodium channel activator (scorpion a toxin, which 
blocks channel inactivation) on sodium channel expression. In these studies, fetal 
cortical neurons in culture responded to channel activation by decreasing Navl.1, 
Navi .2, and Nav1.3 mRNA levels (Dargent and Couraud, 1990; Giraud et al., 1998; Lara 
et al., 1996).
The modification of gene transcription in the electrical stimulation model may 
represent a neuronal adaptation aimed at matching input (stimulation) with output 
(excitability). Like activity-dependent strengthening of synaptic contacts, remodeling of 
the neuronal electrogenic apparatus by altering either ion channel density or effective 
area of excitable membrane, may serve as a means of optimizing information transfer 
between neurons (Spitzer, 1999; Stemmier and Koch, 1999). Cultured cortical pyramidal 
neurons have been shown to adjust their voltage-dependent conductances (including 
VGSCs) in order to increase sensitivity to changes in current injection. By altering these 
conductances, the neuron maintains a stable firing rate corresponding to changes in 
input (Desai et al., 1999). The activity-dependent feedback mechanism which regulates 
the transcription of VGSCs is unknown, but there is evidence that intracellular levels of
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calcium may play a role (LeMasson et a!., 1993; Liu et al., 1998; Marder et al., 1996; 
Turrigiano et al., 1994; Turrigiano et al., 1995; Turrigiano, 1999; Turrigiano and Nelson, 
2000). It has been proposed that low levels of intracellular calcium, resulting from 
periods of decreased neuronal firing, trigger a compensatory increase in VGSC 
expression, which Increases neuronal excitability and firing frequency, and in turn, 
normalizes intracellular calcium levels. Conversely, high levels of intracellular calcium 
resulting from periods of high activity, trigger a decrease in VGSC expression, which 
decreases neuronal excitability and firing frequency, and in turn, normalizes intracellular 
calcium levels (see Fig. 6.2) (Marder and Prinz, 2002; Turrigiano, 1999).
Several experiments support this hypothesis. In cultured rat skeletal myotubes, 
saxitoxin labeling of sodium channels revealed that blockade of calcium channels by 
verapamil (as well as blockade of sodium channels by TJX) caused an up-regulation of 
sodium channel density (Brodie et al., 1989). A similar experiment demonstrated that 
pharmacological blockade of spontaneous electrical activity in skeletal myotubes caused 
a 38-83% increase in VGSC density (Sherman and Catterall, 1984). Electrical activity 
and/or sustained increases in intracellular calcium levels have been shown to decrease 
the level of VGSC mRNA (Kobayashi et al., 2002; Offord and Catterall, 1989; Shiraishi et 
al., 2001). This change was paralleled by an increase in cAMP levels, suggesting that 
stabilization of sodium channel expression and neuronal activity is dependent on a 
balance between calcium-dependent reduction in cAMP levels (which increases VGSC 
expression) and direct actions of calcium as a second messenger (which decreases 
VGSC expression) (Offord and Catterall, 1989). In addition to cAMP-mediated regulation 
of transcription, other calcium-dependent signaling pathways involving CaM kinase II 
and the MAP kinase cascade have been shown to regulate CREB-mediated gene 
transcription (Buonanno and Fields, 1999; Finkbeiner and Greenberg, 1998; Ji and 
Woolf, 2001; Kornhauser et al., 2002; West et al., 2001; West et al., 2002), and the
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decreased sensitivity to 
increased stimulation
Fig. 6.2. Neuronal activity leva! (input) regulates expression of VGSCs, which 
determines neuronal sensitivity and firing rate (output) (Stemmier and Koch, 1999). This 
activity-dependent retuning of the neuronal response curve may be dependent on 
intracellular levels of calcium (Desai et al., 1999; Marder and Prinz, 2002; Turrigiano, 
1999). Dotted lines represent range of stimulation or input current; solid lines represent 
output firing rate. Neurons can maintain a consistently wide range of output 
corresponding to changing input distributions through plasticity of VGSC expression.
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These studies, with the results presented in Chapter 4, suggest that VGSC 
expression is a dynamic process that is continuously modulated by a number of “activity- 
sensors”. Changes in intracellular calcium levels indicate changes in neuronal 
stimulation and input, and these changes are translated into alterations in the molecular 
composition of the neuronal electrogenic membrane.
6.4 VGSC EXPRESSION AND EPILEPSY
In Chapter 5, activity-dependent changes in VGSC expression were addressed in 
the context of epilepsy. WAG/Rij rats, which have spontaneous spike-wave discharges 
(SWDs) similar to those seen in human absence epilepsy, demonstrated up-regulated 
expression of Nav1.1 and Nav1.6 mRNA and protein in layer II-IV cortical neurons within 
the facial somatosensory region (Klein et al., 2003c). This area of cortex matches the 
electrophysiologically-determined region of seizure onset in this model (Meeren et al., 
2002). The dysregulated expression of Nav1.1 and Nav1.6 mRNA and protein parallel 
the age-dependent increase in SWD firing time in this model (Klein et al., 2003c).
The SWD rhythm is thought to result from interactions between neurons of the 
GABAergic reticular nucleus and corticopetal thalamic nuclei (Buzsaki et al., 1988; 
Steriade et al., 1985). Field potential measurements using multi-site depth electrodes in 
WAG/Rij rats have provided evidence that the currents associated with SWD generation 
originate through activation of layer II-IV intracortical neuronal networks (Kandel and 
Buzsaki, 1997). Overexpression of N av l.i and N av i.6 within these neurons could lower 
the threshold for action potential firing and increase the peak current density upon 
activation. In addition, Navi .6 is capable of producing a persistent current (Maurice et 
al., 2001; Raman et al., 1997; Smith et al., 1998), which can underlie neuronal bursting 
and hyperexcitability (Parri and Crunelli, 1998; Tanaka et al., 1999).
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In the WAG/Rij model of absence epilepsy, it is unclear whether the changes in 
expression of Nav1.1 and Nav1.6 are a cause or effect of the seizures. In the former 
case, a molecular defect causing up-regulated expression of Nav1.1 and Nav1.6 could 
lead to hyperexcitable and seizure-prone neurons (Fig. 6.3, left). In the latter case, a 
VGSC-independent defect predisposing neurons to SWD firing could trigger an activity- 
dependent reorganization of the electrogenic membrane, in this case resulting in up- 












up-regulation of VGSC 
expression
Nav1.1
N a v ie
Fig. 6.3. The WAG/Rij model of absence epilepsy has an undetermined genetic basis. A 
molecular defect resulting in increased expression of Nav1.1 and Nav1.6 (left) could 
favor hyperexcitabiiity and lead to spike-wave discharge (SWD) initiation. Alternatively, a 
VGSC-independent molecular defect causing increased SWD firing could trigger 
secondary activity-dependent changes in neuronal gene transcription leading to up- 
regulated expression of Nav1.1 and Nav1.6.
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There are several approaches that could help dissect the relationship between 
SWD firing and neuronal VGSC expression in this model. VGSC transcript knock-down 
strategies or subtype-specific channel blockers could, in the future, help determine the 
relationship between VGSC expression and SWD firing In layer ll-IV cortical neurons in 
the WAG/Rlj model of absence epilepsy.
6.5 CLINICAL PERSPECTIVES
Identification of the dynamic interaction between neuronal activity level and 
VGSC expression could potentially lead to the development of novel therapeutic 
strategies for treating diseases and conditions in which sodium channel expression is 
dysregulated. In diabetes, for example, reversing the up-regulation of Nav1.2 and 
Nav1.6 that occurs in the supraoptic nucleus would prevent the chronically elevated 
vasopressin release. This manipulation would be expected to minimize the deleterious 
effects of vasopressin on the renal glomerulus, and therefore prevent the onset of 
diabetic glomerulonephritis and renal failure.
Neuropathic pain may result, in part, from injury-induced changes in neuronal 
sodium channel expression which lead to hyperexcitability and spontaneous firing. In 
Chapter 4, sodium channel expression was modulated by changes in neuronal activity 
level by a mechanism independent of changes in growth factor availability. These results 
suggest that stimulation applied to injured neurons could alter their expression of 
VGSCs. Currently, functional electrical stimulation, used to either augment or reduce 
neuronal activity associated with coordinated muscle contraction, is being tested in 
nerve-injured subjects. It is conceivable that electrical stimulation could be similarly 
applied to injured nerves, with the hope of reducing pain through modulation of VGSC 
expression.
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Dysregulated sodium channel expression within specific neurons in the epileptic 
cortex represents another potential target for clinical intervention. As the causality 
between altered expression of sodium channels and epileptogenesis becomes better 
elucidated, targeted regulation of sodium channel expression within specific neuronal 
populations in the brain, using either anti-sense technology or targeted gene knock­
down strategies, may be possible. While these approaches are sophisticated, they have 
the potential to be more specific than current anti-epileptic medications, many of which 
have systemic side effects and incompletely understood mechanisms of action.
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